POPULARITY
Cannabis or marijuana is becoming increasingly more popular in the United States for recreational and medical use. What is cannabis? Are there benefits to using it? Is it ok for someone with kidney disease or dialysis to use it? Learn all this and more in today's episode. Joshua Rein, DO, FASN, is a board-certified nephrologist, kidney physiologist, and certified hypertension specialist. He is an Assistant Professor in the Barbara T. Murphy Division of Nephrology in the Department of Medicine at the Icahn School of Medicine at Mount Sinai in NYC and a Staff Physician at the James J. Peters, Veterans Affairs Medical Center. He received his medical degree from the New York College of Osteopathic Medicine, completed internal medicine at Mount Sinai Beth Israel, and completed clinical and research nephrology fellowships at Mount Sinai Hospital. Dr. Rein is interested in the effects of cannabis and cannabinoids on kidney health and disease given their widespread growing popularity despite an uncertain impact on health. Dr. Rein's research, funded by a Veterans Affairs Career Development Award, utilizes preclinical animal models to characterize the kidney endocannabinoid system and examine the physiological impact of cannabinoids on the regulation of fluid and electrolyte balance by the kidney. His clinical research focuses on the risks, benefits, and clinical significance of cannabis consumption among people with kidney disease and those at risk for developing kidney disease. Additional Resources: Nephrologist's Guide to Cannabis Cannabis Usage Study AJKD Blog Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.
This podcast will discuss the CPS Position Statement on an Affirming Approach to Caring for Transgender and Gender-diverse Youth: Part 2. In this episode, listeners will 1) discuss the use of hormone blocking therapy in gender diverse youth, 2) discuss gender affirming hormones, 3) briefly discuss gender affirming surgery options, and 4) apply your knowledge to a clinical case! The podcast was created by Annaliese Beck-McKenzie, a fourth-year medical student at the University of British Columbia, with the guidance of Dr. Ashley Vandermorris, Staff Physician in the Division of Adolescent Medicine at the University of Toronto SickKids Hospital.
This podcast will discuss the CPS Position Statement on An Affirming Approach to Caring for Transgender and Gender-diverse Youth: Part 1. The podcast was created by Annaliese Beck-McKenzie, a fourth-year medical student at the University of British Columbia. This podcast was created with the guidance of Dr. Ashley Vandermorris, Staff Physician in the Division of Adolescent Medicine at the University of Toronto SickKids hospital. This PedsCases podcast focuses on important terminology, gender identity development, assessment of gender diverse youth, and diagnosis of gender dysphoria
In this episode, Sharon is joined by Dr. Natalie Bello, Director of Hypertension Research, Staff Physician and Associate Professor of Cardiology at Cedars-Sinai Medical Center.After learning that 80% of heart disease is preventable in medical school, Dr. Bello decided that focusing her career on helping people stay healthy, optimize their risk factors, and live long lives was an easy choice to make. Hypertension, also known as “The Silent Killer,” is a leading global contributor to heart disease. A common myth is that heart disease disproportionately affects men when, in fact, it is the number one killer of both men and women. This misinformation has major consequences, namely that women experiencing chest pain wait 29% longer in the emergency room to be seen by a doctor than their male counterparts. Dr. Bello shares that just because a woman doesn't present their pain the same way as a man doesn't mean that they aren't experiencing the same pain. Being your biggest health advocate is the best way to regain your agency in heart health. Sometimes, for a woman, that may look like firmly declaring that your chest pain has brought you to the emergency room, stating your risk factors and that you must be treated for potentially having a heart attack.Dr. Bello recommends the tests for anyone with chest pain or interested in improving their heart health, like an EKG, troponin, stress test, or angiogram. In order to assess personal risk factors, the Pooled Cohort Equations to Prevent Heart Failure (PCP-HF) or PREVENT are most used. Dr. Bello then discusses the mechanics of hereditarily passing down heart conditions between genders and the importance of increasing the number of studies on pregnancy's impact on the body. Episode Outline(00:55) Meet Dr. Bello(01:35) 80% of Heart Disease Is Preventable(05:14) PSA: Women Wait Longer in the ER With Chest Pain(12:46) Knowledge Is Power: Know Your Hereditary and Gender-Specific Risk FactorsConnect with SharonConnect with Sharon on LinkedIn: Sharon KedarLearn more about Innovate and Elevate innovateandelevatepodcast.comSubscribe to Innovate and Elevate on YouTubeJoin the newsletter to receive the latest episodes in your inbox: Innovate and Elevate NewsletterConnect with Dr. BelloFollow Dr. Bello on LinkedIn Additional ResourcesWomen and Black adults wait longer to be seen in the ER for chest pain By American Heart Association News PREVENT Online CalculatorASCVD Risk Estimator App How Heart Palpitations Led Oprah to Discover She Was Approaching...
As we continue through cold and flu season after the peak of COVID-19, it can be difficult to decide as students when we can still make it to class and when we ought to stay home. Dr. David Dafashy, Medical Director and Staff Physician at the W&M Student Health Center, is here to clear up some misconceptions. We talk about the difference between upper respiratory infections and bacterial illnesses, what we should do when we experience a particular set of symptoms, and when we should consider making a visit to the Student Health Center. Stay healthy!Resources:Student Health Center websiteHealth Center appointment webpage
The Hamilton Today Podcast with Scott Thompson: What is Long COVID, and what have we learned about it since we first started hearing about abnormal reactions to the virus way back in 2020? Most toy drives in Ontario will be getting ready to do their final push for donations over the next few days, and it's a push they say is desperately needed. With Trudeau's announcement of a cap on the oil and gas sector, Ottawa is now flirting with its third carbon tax, says the Canadian Taxpayer Federation. Writing in the Globe and Mail, Kelly Cryderman says that it is not crazy for Canadians to think that the carbon tax is hitting their pocketbooks. Writing in the Toronto Sun, Joe Warmington notes that “they can spend millions of taxpayer dollars to rename the main square in Toronto's downtown, but no one will ever call it Sankofa Square.” The Grape Growers of Ontario have released their reaction to the changes around where alcohol can be sold in the province. As we approach the end of a tumultuous economic year, are we seeing signs of improvements for 2024? Final regulations for the Online News Act show the amount of funding private broadcasters will get through the government's $100-million deal with Google will be limited, with an even lower cap for the CBC. Guests: Dr. Isaac Bogoch. Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto Sawyer Bogdan, Online Journalist for Global News Franco Terrazzano, Canadian Taxpayers Federation, Federal Director Kelly Cryderman, Reporter & Columnist, Globe and Mail Joe Warmington, Columnist with the Toronto Sun Debbie Zimmerman, CEO of the Grape Growers of Ontario Colin Mang, Assistant Professor of Economics, McMaster University Jeffrey Dvorkin, Senior Fellow at Massey College, Former Director of Journalism at the University of Toronto-Scarborough and author of Trusting the News in a Digital Age Scott Radley, Host of The Scott Radley Show and Columnist with the Hamilton Spectator
In the realm of healthcare, the need for specialized care for Alzheimer's and Dementia patients has never been more pressing. As the world continues to grapple with the complexities of these conditions, innovations and shifts in care models are needed. In this podcast episode imagine a future where Alzheimer's and Dementia care is not just an afterthought but a priority. This episode will take you on an insightful journey into the world of Dementia care, spotlighting the groundbreaking work of MemoryCare, a nonprofit organization based in Asheville, North Carolina dedicated to empowering patients and caregivers. Our guests, Dr. Stelley Gutman, a seasoned geriatric specialist, and Elizabeth Lackey MSW, Lead Care Manager, guide us through the labyrinth of Alzheimer's and Dementia care, from diagnosis to innovative care models. Are you aware of the toll caregiving can take on one's health? We explore this with Dr. Gutman and Ms. Lackey, delving into the significant health impact of caregiving and the potential solutions offered by their program. They also shed light on their view on the collaborative role of hospice and palliative care for afflicted families and the patient. We also touch on the utilization of hospice facilities and their potential for respite care. In the final segment of our conversation, we discuss CMMI's proposed GUIDE model. Reflecting on the importance of collaboration in healthcare. Tune in to this enlightening episode and emerge with a richer understanding of Dementia care, the promising strides being made in the field, and most importantly for our listeners the potential collaboration opportunities. You won't want to miss this. Join us. Guest: Dr. Stelley Gutman, Staff Physician at MemoryCareElizabeth Lackey, Lead Care Manager, MemoryCare and The SECU Center for MemoryCare Host:Chris Comeaux, President / CEO of TCNTeleios Collaborative Network / https://www.teleioscn.org/tcntalkspodcast
Synopsis: Bernard Coulie is the President and CEO of Pliant Therapeutics, a clinical stage biopharmaceutical company focused on discovering and developing novel therapeutics that seek to halt progression of fibrotic diseases — ultimately preserving organ function. Bernard discusses the arc of his career and shares his perspective on the European biotech ecosystem compared to the United States, and how that's changed over the last 10 years. He talks about the importance of having access to lots of capital in the early days of starting a company. He discusses fibrotic disease, the high medical need to treat it, and the indications they are pursuing. Finally, he discusses the challenges of focusing on multiple therapeutic areas and the advice he would give to others. Biography: Pliant CEO Bernard Coulie, M.D., Ph.D., brings to the company more than 15 years of senior leadership experience and drug development expertise. He joined Pliant from ActoGeniX (acquired by Intrexon Corporation in February 2015), where he was CEO, Chief Medical Officer and Co-Founder. In these positions, Dr. Coulie played an integral role in advancing the company's unique technology platform for oral delivery of biologics from early discovery stage through Phase 2 studies. Prior to ActoGeniX, Dr. Coulie held various positions with increasing responsibilities in drug discovery and clinical development at Johnson & Johnson Pharmaceutical Research and Development Europe. At Johnson & Johnson, he served as Therapeutic Area Leader Internal Medicine, managing a portfolio of products in GI, metabolic diseases and inflammation/immunology, ranging from early drug discovery through Phase 2 studies. Earlier in his career, Dr. Coulie was a Staff Physician in the Department of Gastroenterology and Hepatology at Mayo Clinic (Rochester, MN), Assistant Professor in Medicine at Mayo Medical School and a Mayo Foundation scholar. Dr. Coulie serves as Chairman of the Board of Directors of SQZ Biotechnologies, a publicly-traded cell therapy biotechnology company, as Independent Chairman of Dualyx, a privately-held biotechnology company based in Belgium and as an Independent Director at Calypso Biotech, a privately-held biotechnology company based in the Netherlands. Dr. Coulie holds an M.D. and Ph.D. from the University of Leuven, Belgium. He is a board-certified internist and holds an MBA from the Vlerick Management School, Leuven, Belgium.
JCO PO author Dr. Apar K. Ganti shares insights into his JCO PO article, “Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With ERBB2 Mutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry Study.” Host Dr. Rafeh Naqash and Dr. Ganti discuss clinical decision-making regarding biopsy; HER2 amplification, mutation, and targeted therapy; drug combinations; and aspects of the TAPUR and DESTINY-Lung studies. Click here to read the article! TRANSCRIPT Dr. Abdul Rafeh Naqash: Hello and welcome to JCO Precision Oncology Conversations, where we bring you engaging conversations with authors of clinically relevant and highly significant JCO PO articles. I'm your host, Dr. Abdul Rafeh Naqash, Social Media Editor for JCO Precision Oncology, and Assistant Professor at the University of Oklahoma Stephenson Cancer Center. Today we are joined by Dr. Apar Kishor Ganti. Dr. Ganti is a Professor of Medicine and associate director of clinical research at the Fred and Pamela Buffett Cancer Center at the University of Nebraska Medical Center. He's also a staff physician at the VA Nebraska Western Iowa Healthcare System. Dr. Ganti is the lead author of the JCO Precision Oncology article titled "Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With ERBB2 Mutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry Study," which is also the TAPUR Study. Dr. Ganti, thank you so much for joining us today. Dr. Apar Kishor Ganti: Thank you for having me. I'm happy to be here. Dr. Abdul Rafeh Naqash: For starters, Dr. Ganti, this is one of the trials from the TAPUR Basket study. So I wanted to take this opportunity since this is an ASCO initiative that has been there for a few years now. Could you tell us a little bit of background about the TAPUR initiative, what kind of trials are being run or have been run, and how it all started, basically? Dr. Apar Kishor Ganti: The TAPUR Study or the Targeted Agent and Profiling Utilization Registry Study is a pragmatic basket trial which evaluates the anti-tumor activity of commercially available targeted agents in patients with advanced cancers and tumors that have potentially actionable genomic alterations, like mutations, amplifications, etc. And this has multiple arms in multiple malignancies, using drugs that are currently approved in different indications and not necessarily approved for the indication that's being studied. But there's preclinical data that suggests that that particular drug may potentially be active in patients whose tumors harbor those mutations. For example, this present study that we conducted utilized a combination of pertuzumab and trastuzumab, both of which are FDA-approved for the treatment of patients with HER2-positive breast cancers. And we analyzed the efficacy of the combination of these two drugs in patients with lung cancer who had either a HER2 mutation or an amplification of HER2. Dr. Abdul Rafeh Naqash: Thank you so much for giving us that background. Going to this study specifically, which is one of the very interesting TAPUR studies, what I'm reminded of especially is NCI-MATCH, for example, which runs on a similar premise to this study, where we've seen some successes and some not as exciting combination approach successes that is what we would have wanted to see. For lung cancer specifically, as you and I both know and perhaps many of the listeners know, there's a lot of actionable drivers that have target therapies that are approved, could you touch on some of those to give a background on where the field currently lies and what are some of the important steps with respect to obtaining next generation sequencing, perhaps in patients. So what your practice is and what you would recommend for these individuals? Dr. Apar Kishor Ganti: Certainly, non-small cell lung cancer, or non-squamous non-small cell lung cancer, to be more precise, seems to be the poster child for next-generation sequencing. And the importance of NGS testing cannot be overemphasized in these patients. For example, right now we have multiple different drivers that have drugs approved for the management of these patients. The first among them, obviously, was EGFR or epidermal growth factor receptor. And that has been followed fairly successfully by targeting ALK, ROS1, now, more recently, RET, MET, KRAS, and HER2. So if you look at lung adenocarcinomas, almost half of the patients will have a tumor with a mutation that is targetable. And so it's very important to make sure that these patients are tested for, before initiating any therapy. What makes it more important is that the standard of care for patients with non-small cell lung cancer without driver mutations is either immunotherapy or chemoimmunotherapy. And we have found that if a patient has a driver mutation, especially EGFR or ALK, even if their PD-L1 expression is extremely high, their response to checkpoint inhibitors is negligible. And so it is important to make sure that we understand what their molecular status is before starting any treatment in these patients. And I think the key point here is that every patient with advanced non-small cell lung cancer should have next generation sequencing studies done prior to initiation of treatment. Dr. Abdul Rafeh Naqash: Absolutely. And in your practice, Dr. Ganti, do you tend to do liquid biopsies concurrently when you get a new individual with a diagnosis of lung cancer, or do you do it at some other time point? Dr. Apar Kishor Ganti: Liquid biopsies, I tend to get them, but not as frequently as some would like. I tend to believe more in tumor biopsies, and I would get liquid biopsies only in the setting where a tumor biopsy is not feasible or if I feel that the patient needs treatment more rapidly than can be expected if I got a tissue biopsy. Liquid biopsies, in my opinion, are good, but they're very dependent on the tumor fraction that is present in the sample that you send. As you very well know, not all patients who have a driver mutation necessarily shed the mutation into the blood. And therefore, even if a patient has a driver mutation in a tumor, there is a small chance that the liquid biopsy may not detect it. So I tend to be more in favor of getting tumor biopsies for next-generation sequencing. In situations where the tumor fraction is high, the concordance between tumor biopsies and liquid biopsies is fairly good. Dr. Abdul Rafeh Naqash: Thank you so much for that very important clinical decision-making thought process. At least in my practice, when tissue is often the issue, as you very well know, where you don't either have enough tumor cells or the biopsy is just enough to tell you whether it is squamous or non-squamous and not enough for any further sequencing, I try to get liquid biopsies whenever feasible and appropriate so that at least we can rule out some of the driver alterations before I put a patient on immunotherapies, due to the concern for subsequent toxicities if there are driver alterations. But I totally agree, I think tissue is definitely the standard, gold standard. And if you have overlapping mutations in tissue and liquid, then obviously it increases your confidence of treating that individual with that targeted therapy. But in general, tissue definitely, at least we should try to emphasize, and I try to do this often when I get a call from a community oncologist. I'm pretty sure you do the same where we ask for multigene broad gene testing NGS, so that especially when you have HER2 mutations, for example, you won't necessarily capture those as you show on your study here. Now, going to your study, Dr. Ganti, could you tell us a little bit more about HER2 mutations and amplifications? And there's different levels of evidence where amplification may not lead to expression or expression may not lead to amplification. And then there is a separate category of HER2 mutations. And a lot of what we know for HER2 is from breast cancer. And recently, in the last two to three years now, is for lung cancer also. Could you tell us about how the field is shaping from a HER2 mutational landscape, an amplification landscape, in the lung cancer field? Dr. Apar Kishor Ganti: As you rightly said, most of our knowledge from HER2 is from the breast cancer world. And frankly, I think we've been spoiled by the data on breast cancer. So, unlike in breast cancer, lung cancer seems to have a much lower frequency of HER2 alterations. And while in breast cancer, HER2 amplification seems to be important and predictive for response to HER2-targeted agents, in lung cancer, we see a combination of mutations and amplifications. So, in a large TCGA study, mutations in HER2 seem to occur in about 2% of all lung cancers. And amplification seems to be occurring in approximately a similar proportion of different patients. So, they seem to be mutually exclusive as best as we can tell. And, unlike in breast cancer, where HER2 amplification seems to be directly associated with protein over-expression and response to tumor, the data in lung are much less robust. And so, it is not necessarily that an amplification will translate into a prediction of response to a HER2-targeted agent. And we and certain other studies have shown that patients who have HER2 amplification may not respond as well to HER2-targeted therapy as opposed to, for example, patients with HER2 mutations. So, that seems to be the discrepancy in HER2 amplification and HER2 mutations when you look at lung cancer versus breast cancer. And that's another reason why we are doing the TAPUR study at the various arms because what works in one specific cancer with the same mutation or same abnormality may not necessarily work in other cancers. Dr. Abdul Rafeh Naqash: Absolutely. Thank you for indulging into that side of things. Now, going back to your trial, could you tell us a little bit of background on the eligibility criteria, how you chose some of the different mutations? What were the levels of evidence for some of those mutations from a pathogenicity standpoint, and then what were your endpoints, since this is a clinical trial with a Simon two-stage design? Dr. Apar Kishor Ganti: Patients who were eligible for the trial included all patients with advanced lung cancer who did not have another FDA-approved treatment or were not candidates for another treatment. They all should have been 18 years or older at the time of diagnosis and have lung cancer with either ERBB2 amplification or we looked at 13 specific mutations, insertions, or deletions, and, if the patient had any of those abnormalities identified by any clear approved next-generation sequencing testing platform, then they would be eligible for the study. We chose these because of how frequently these specific mutations occurred in lung cancer and other cancers. And so, these 13 abnormalities were chosen from the host of HER2 mutations that you can see. Patients should not have received a previous HER2 inhibitor, obviously, and their LV ejection fraction should be normal because of the known risk of decreasing cardiac function with HER2-targeted therapy. They were treated with pertuzumab every three weeks and then combined with trastuzumab. Trastuzumab was given at a loading dose, initially of 8 milligrams per kilogram, and in subsequent cycles, we used 6 milligrams per kilogram. The dose of pertuzumab was a flat dose of 840 milligrams for the first dose and 420 milligrams for subsequent doses. We continued the treatment till progression or excessive toxicity or patient withdrawal of consent. The endpoints were disease control, which we defined as objective response or stable disease for at least 16 weeks duration. Other endpoints were progression-free survival, overall survival, duration of response, and, of course, safety. We used a Simon two-stage design, as you said. The null hypothesis was that the disease control rate would be 15%, alternative hypothesis was 35%, the power was 85%, alpha was at 10%. So, if in the first stage, less than two out of ten patients had disease control, then the cohort would be closed for futility. If two patients or more had disease control of the first 10, then we expanded to an additional 18 patients for a total study size of 28. So, as far as safety analysis, any patient who received even a single dose of treatment was included in that safety analysis. Dr. Abdul Rafeh Naqash: Thank you so much for giving us those details about the cohort. Going to the mutation or the amplifications, I'm looking at the cohort, so it seems like more or less, to some extent, there was an equal distribution of the mutations. 50% of individuals had mutations and then around 45%, 43% had amplifications. Did that play into your expectation of how the cohort did in terms of responses or the primary endpoints that you had set? Did you see differences based on those findings of mutations versus amplifications. Dr. Apar Kishor Ganti: Yes, we did. The disease control rate was 37%, with an overall response rate of 11%. And when you looked at patients who had a partial response, which is three patients, all of them had ERBB2 mutation. And of the patients who had stable disease, only two patients out of seven had an amplification. Five patients had the mutation. So, again, this was similar to what we had expected, that based on previous studies, patients with mutation tend to respond better than patients with alterations. Dr. Abdul Rafeh Naqash: Definitely. And going to one of the striking figures that you have in this manuscript, of course, you have the waterfall plot, and then you have the swimmer's plot and the spider plot. I'm very intrigued personally by the spider plot, which is the Figure 3 in your paper, especially with this individual that had this long, durable partial response. I believe this was the same individual with the mutation. I believe it was this 776 insertion. Was there anything, any other aspect that could have contributed to this response, or does this mutation, does it have any strong preclinical data of why the activity offer to direct therapy might be more pronounced in this mutation that you came across? Dr. Apar Kishor Ganti: Not to my knowledge. I don't think we found anything specific or different about this particular patient compared to the others. So, as far as the mutation itself is concerned, it's a fairly common mutation, the G776 insertion. It is one of the most common mutations seen in lung cancer, and studies have shown that patients with the mutation tend to respond. But why this patient responded so long, it's difficult to say. I wish we were able to find out, but unfortunately, we were not able to. Dr. Abdul Rafeh Naqash: Sure. Another question that I wanted to ask you since this falls into the precision medicine basket study questions. Does TAPUR have a different endpoint for different sub-studies? Because I vaguely remember coming across another paper where I believe a 16-week disease control was also the endpoint. So, is that something universal in TAPUR, or is it specific for specific tumor types and different combination approaches? Dr. Apar Kishor Ganti: I believe that this is a more generalized feature of the TAPUR study, the stable disease for 16 weeks as a marker of response. Of course, different arms have additional endpoints, but I think this is one of the more common ones. Dr. Abdul Rafeh Naqash: Now, there has been some work, as you very well pointed out in your paper as well, from others related to HER2 mutations, especially the DESTINY-Lung study. Could you tell us a little bit about that for listeners who may not be well aware of the DESTINY study with trastuzumab deruxtecan targeting the HER2 mutations? Dr. Apar Kishor Ganti: So, DESTINY-Lung01 was a study of patients with ERBB2 mutated lung cancer. That study just looked at mutation-positive patients as opposed to what we did, looking at both mutation and amplification. And that study showed an overall response rate of 55%, which was much higher and led to the approval of fam- trastuzumab-deruxtecan in this group of patients. And so, one of the differences between our study and trastuzumab deruxtecan DESTINY-Lung01 study, is that our study included patients with both mutations and amplification and our study did not include any cytotoxic drug. And I believe that was one of the big differences, which may make the results of our study intriguing and potentially useful to patients who may not be able to tolerate a cytotoxic agent. Because, as you know, fam-trastuzumab-deruxtecan has the cytotoxic binder. It's an ADC and has been known to have some toxicities. And the thing about lung cancer is that these patients are relatively frail and may not be able to tolerate it. And so, that's one of the major differences, a portion at least for this combination, even though the response rates are much smaller than what we see with fam-trastuzumab-deruxtecan. Dr. Abdul Rafeh Naqash: And from your practice, have you started using this combination from your study as a potential approach for individuals who may not be candidates for trastuzumab deruxtecan in your clinic? Dr. Apar Kishor Ganti: I have not as yet because I have not come across a patient who would be eligible for this combination. In my practice, as we have TAPUR open, we have the tucatinib-trastuzumab arm that opened after this arm closed. So my priority is to try and enroll patients onto that cohort. And so I currently have one patient on that. And as you know, this is not a very common alteration, so we don't have as many patients with this. But definitely, this would be a combination that I would put patients on if I felt that they were not a candidate for fam-trastuzumab-deruxtecan. Dr. Abdul Rafeh Naqash: So, Dr. Ganti, what's the next step after this since your study didn't meet some of its endpoints? What are you planning, or is there a plan to expand on this through the TAPUR mechanism? Dr. Apar Kishor Ganti: Right now, I don't think that there's a mechanism through TAPUR to expand this particular cohort because there is also another cohort that opened subsequently with tucatinib and trastuzumab. But I think it would not be unreasonable to study this combination in patients who are not candidates for fam-trastuzumab because of the differences in toxicity. So that would be where I would potentially see a role for this particular combination, and I think it should be studied in that setting. Dr. Abdul Rafeh Naqash: Excellent. Now, I try to dedicate a section of this conversation for provocative discussions that may not be addressed in your paper, but I still like to get insights from experts in the field such as yourself. So comparing it to the NCI-MATCH or some other precision medicine-based initiatives, we do often see that mutations that we think might be driving the process don't necessarily lead to really high or really promising responses to targeted therapies. So in this case, do you think, from a futuristic standpoint, a proteomic-based assay, since I think you work in the proteomic space as well, that would be an interesting way to look at whether signaling actually is altered from a mutation or an amplification, suggesting that that is driving the process, so would be a more attractive target than just looking at a mutational signature? Dr. Apar Kishor Ganti: I think definitely that should be the way we should be looking at these kinds of studies, because even in this study, even if you look at fam-trastuzumab-deruxtecan and the DESTINY-Lung01 study, we have patients who have definite, identified drivers, and even there, only about half of the patients responded. It was much smaller in our study. But basically what I'm getting at is with the best of the drugs that we have today, only half of our patients respond with HER-2 mutations, for example. So I would definitely favor a more integrated approach to identifying those patients who would be candidates for these targeted agents and not just simply relying on a specific mutation. Since we are being provocative, I would go one step further and say, “Hey, we have AI. And there are currently AI-based technologies which look at the entire next-generation sequencing profile and try to identify which drugs could potentially be effective in those patients based on a complete understanding of their entire tumor genetic profile, rather than just looking at one or two, or three mutations.” So that, I think, would be a much more robust approach through precision medicine. So, like you just said, that patient that we had who had a prolonged response, we don't know why he or she had a prolonged response. And maybe if we identified a pathway or pathways which were overexpressed or more active in that particular tumor setting, we would be able to identify better targets and better approaches for those patients. So I think that is the way to go in the future. Dr. Abdul Rafeh Naqash: Excellent. Thanks for indulging into that provocative discussion and hopefully maybe five years down the line when we meet again or run across each other at ASCO, we will say, “Oh, it did actually happen, that multiomics is being used in a way that is suited for the need of the patient.” So matching the right patient to the right therapy at the right time. So, Dr. Ganti, the last section is going to be dedicated to you as an individual. So you've had a very successful, brilliant career as a clinical trialist and as a lung cancer expert. Tell us, for the sake of our listeners and perhaps some of the early career junior investigators, what your career trajectory has been briefly, and what are some of the things that you felt were successful that could provide advice and insights to people who are earlier in their careers and trying to emulate what perhaps you have done or you are doing? Dr. Apar Kishor Ganti: Well, that is a big one. I never thought of myself as being a role model for anyone, far less someone who's at the beginning of their career. But what I have always mentioned to students and residents and fellows is basically there is no substitute for hard work. Luck plays some role in this because you need to be at the right place at the right time for some of it, but hard work definitely will pay off. And the other thing that is important is not to get disheartened if your first clinical trial gets rejected or concept gets rejected, or if your first grant gets unscored. That is part of life, and persisting is probably the best way to continue. Also, continuing to believe in yourself. I've seen a lot of folks, especially once they get into their second or third year after fellowship when things are not going the way they want to, they start to wonder, “Am I suited for this job? Am I the right person? Am I doing this correctly? Should I be doing something else?” And I think it's just a matter of time before they will find success. And also, the other thing is, if one particular approach does not work, there are always other ways that you can look at. So, for example, if you extend a bunch of clinical trial concepts that do not work out, you could potentially look at other ways of answering questions. For example, you could do retrospective analyses, come up with provocative, hypothetical generating questions that could be answered in the future in a prospective study. So there are lots of avenues to do that. And I think I was benefited by my mentors who helped me see this relatively early in my career. Dr. Abdul Rafeh Naqash: Thank you so much, Dr. Ganti, for all those valuable insights that you've learned over your career and hopefully will help some of the listeners. Before we finish, I'm going to ask you three rapid-fire questions that hopefully will let our listeners--give them a little bit of a sneak peek into you as a person. And you get like five seconds for each question. And they're not complicated questions. My first question to you is what is your favorite food? Dr. Apar Kishor Ganti: Thai food. Dr. Abdul Rafeh Naqash: What is your favorite place to go for vacation? Dr. Apar Kishor Ganti: South Africa. Dr. Abdul Rafeh Naqash: And what is your favorite hobby? Dr. Apar Kishor Ganti: Reading. Dr. Abdul Rafeh Naqash: Well, thank you so much again, Dr. Ganti. This was a very interesting conversation and hopefully, when you or others have other TAPUR-related trial results, perhaps they will again choose JCO PO as a destination for that work. Thank you for listening to JCO Precision Oncology Conversations. Don't forget to give us a rating or review and be sure to subscribe so you never miss an episode. You can find all ASCO shows at asco.org/podcast. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Guest Bio: Dr. Apar Kishor Ganti, MD, MS, is professor of medicine and Associate Director of Clinical Research, Fred & Pamela Buffett Cancer Center at the University of Nebraska Medical Center and Staff Physician at VA Nebraska Western Iowa Health Care System. Guest COIs: Apar Kishor Ganti, MD, MS Consulting or Advisory Role: AstraZeneca, Jazz Pharmaceuticals, Flagship Biosciences, Cardinal Health, Sanofi Genzyme, Regeneron, Eisai Research Funding: Apexigen (Inst), NEKTAR Pharmaceuticals (Inst), TopAlliance BioSciences Inc (Inst), Novartis (Inst), Iovance (Inst), Mirati Therapeutics (Inst), Chimeric Therapeutics (Inst)
The medical and dental students who kept polio patients alive by hand-ventilating them around the clock are among the cast of characters in this incredible story. This podcast is intended for US healthcare professionals only. To read a full transcript of this episode or to comment please visit: https://www.medscape.com/features/public/machine Eric J. Topol, MD, Director, Scripps Translational Science Institute; Professor of Molecular Medicine, The Scripps Research Institute, La Jolla, California; Editor-in-Chief, Medscape Hannah Wunsch, MD, MSc, Professor of Anesthesiology and Critical Care Medicine, Department of Anesthesiology, University of Toronto; Staff Physician, Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada The Autumn Ghost, Hannah Wunsch, MD; https://greystonebooks.com/products/the-autumn-ghost Why we can thank a polio emergency for the birth of intensive care; Nature 618, 234-235 (2023), Eric Topol; https://doi.org/10.1038/d41586-023-01830-3 You may also like: Medscape's Chief Cardiology Correspondent Dr John M. Mandrola's This Week In Cardiology https://www.medscape.com/twic Discussions on topics at the core of cardiology and the practice of medicine with Dr Robert A. Harrington and guests on The Bob Harrington Show https://www.medscape.com/author/bob-harrington For questions or feedback, please email: news@medscape.net
Dr. Andrea Furlan - 8 Steps to Conquer Chronic Pain: A Doctor's Guide to Lifelong Relief. This is episode 588 of Teaching Learning Leading K12, an audio podcast. ANDREA FURLAN, MD, PhD, is an Associate Professor in the Department of Medicine at the University of Toronto and a Staff Physician and Senior Scientist at the Toronto Rehabilitation Institute. Her YouTube page has more than 487,000 subscribers and more than 42 million views. She received a CIHR New Investigator Award, and her research focus is on treatments of chronic pain including medications, complementary and alternative therapies, and rehabilitation. Today we are focused on Andrea's book - “8 Steps to Conquer Chronic Pain a Doctor's Guide to Lifelong Relief. Great conversation. So much to learn and think about! Enjoy! Before you go... Could you do me a favor? Please go to my website at https://www.stevenmiletto.com/reviews/ or open the podcast app that you are listening to me on, and would you rate and review the podcast? That would be so cool. Thanks! If you are listening on Apple Podcasts on your phone, go to the logo - click so that you are on the main page with a listing of the episodes for my podcast and scroll to the bottom. There you will see a place to rate and review. Could you review me? That would be so cool. Thank you! Hey, I've got another favor...could you share the podcast with one of your friends, colleagues, and family members? Hmmm? What do you think? Thank you! Thanks for sharing! Thanks for listening! Connect & Learn More: https://www.doctorandreafurlan.com/ https://www.youtube.com/c/DrAndreaFurlan https://www.doctorandreafurlan.com/book https://www.instagram.com/dr.andrea.furlan/ https://twitter.com/adfurlan https://www.facebook.com/dr.andrea.furlan https://www.linkedin.com/in/drandreafurlan/ andrea.furlan@uhn.ca andrea@doctorandreafurlan.com Length - 55:37
DR. ANDREA FURLAN, MD, PhD, is an Associate Professor in the Department of Medicine at the University of Toronto and a Staff Physician and Senior Scientist at the Toronto Rehabilitation Institute. Her YouTube page has more than 487,000 subscribers and more than 42 million views. She received a CIHR New Investigator Award, and her research focus is on treatments of chronic pain including medications, complementary and alternative therapies, and rehabilitation. https://www.doctorandreafurlan.com/Get the Book - 8 Steps to Conquer Chronic Pain: A Doctor's Guide to Lifelong Relief:https://www.doctorandreafurlan.com/book
-What is chronic pain and how does it relate to codependency? -How might codependents sabotage their health? -What are the initial steps we can take to practice self-care and prevent conditions like chronic pain? Welcome to Episode 129! This week, I had the pleasure of interviewing Dr. Andrea Furlan, MD, PhD, on the connection between codependency and chronic pain. In the episode, Dr. Furlan educates us on what chronic pain is and how codependency a) contributes to the development of chronic pain and b) ways that codependents may sabotage their healing from chronic pain since we can't practice self-care. You'll hear ways Dr. Furlan has navigated codependency in her own life, including with her chronic pain patients. We explore Dr. Furlan's eight steps to curing chronic pain and discuss ways you can begin to implement them in your life asap! It's a must-listen! Links for the show: Sign up for the newsletter to receive all things codependummy: https://keap.app/contact-us/2302598426037497 Journal! The Confiding Codependummy: 30 Days of Journaling Prompts for a Less-Codependent and More-Conscious YOU for just $1 a day. www.codependummy.com/toolsforhealing FREEBIE! The Self-Validation Challenge: Learn to validate your GD self: www.codependummy.com/challenge Money! Funds! Help support the show via a one-time donation via secure Paypal link: https://www.paypal.com/donate/?hosted_button_id=RJ3PSNZ4AF7QC Work with me! Email marissa@codependummy.com to inquire about psychotherapy, coaching, or coming on the show! More on this week's guest: Dr. Andrea Furlan, MD, PhD, is an Associate Professor in the Department of Medicine at the University of Toronto and a Staff Physician and Senior Scientist at the Toronto Rehabilitation Institute. Her YouTube page has more than 487,000 subscribers and more than 42 million views. She received a CIHR New Investigator Award, and her research focus is on treatments of chronic pain including medications, complementary and alternative therapies, and rehabilitation. https://www.iwh.on.ca/people/andrea-furlan https://youtu.be/hxP5XKcNGmI https://www.instagram.com/dr.andrea.furlan/ Deets on the episode: We begin by hearing Dr. Furlan's definition of codependency: in a relationship between two people, one person puts the interests of another above their own to help them succeed. Dr. Furlan describes ways that she learned about codependency in addiction medicine and started to see it in her patients who would refuse to take care of themselves. Dr. Furlan opens up about codependency in her own life where, as a mother, she has had to find the balance between doing the right thing for her and her children related to caretaking. She reveals how she and her colleagues often combat codependency with their patients. “We work harder than our patients.” She details empathy research on doctors who prioritize the needs of their patients over their own which contributes to burnout. Can you relate? We shift focus to Dr. Furlan's expertise: chronic pain. We learn what the definition of chronic pain is, the difference between acute pain versus chronic pain, and how it relates to the alarm system in a house. Thing is, with chronic pain, the physical “alarm system” is broken. Dr. Furlan and I discuss the ways she has seen her patients become codependent with their chronic pain where they form an identity as a “chronic pain patient.” We also hear her struggles with codependent patients who have difficulty practicing self-care and sabotage their chronic pain recovery. What's a codependent trying to heal from chronic pain to do? Dr. Furlan suggests these eight steps which she details in her book: Accept you have chronic pain Control your emotions Sleep Nutrition Communication Medication Exercise Goals in life Dr. Furlan leaves us with reminders to practice self-love, compassion, and to create healthy community. Thanks for coming on Dr. Furlan! And thank you for listening, my dear listener! PLEASE: Rate. Review. Subscribe. Share. We need more ratings on Spotify! TY! -The Self-Validation Challenge - free 30-day guide to providing yourself with all the validation you seek: www.codependummy.com/challenge -Get your copy of the Confiding Codependummy: 30 days of journaling prompts for a less-codependent and more-conscious you! www.codependummy.com/toolsforhealing -If you are wanting to dive into your codependency deeper one-on-one, please email marissa@codependumy.com to work with me! -Sign up for the newsletter: https://keap.app/contact-us/2302598426037497 -Support the show via a one-time secure donation: https://www.paypal.com/donate/?hosted_button_id=RJ3PSNZ4AF7QC See you next week!
The Hamilton Today Podcast with Scott Thompson: Former Mayor of the City of Hamilton Bob Wade has passed away. Current Mayor Andrea Horwath made the announcement at City Council today. Bob Wade served as the mayor of Hamilton from 2000–2003. He was the first mayor following amalgamation. We talk with former Mayors Larry Di lanni, Fred Eisenberger, and current mayor Andrea Horwath. Tomorrow is the Coronation of King Charles III. What does this event and the U.K. monarchy mean for Canadians in 2023, how does it affect us politically? You may have noticed that Dave Woodard is absent from the anchor's chair this afternoon. That's because he is off on a very tough assignment… covering the opening day of Canada's Wonderland!! The World Health Organization has declared that the COVID-19 pandemic is no longer a global health emergency. It is all coming up on the Hamilton Today Podcast! Guests: Larry Di Ianni. Former Mayor, Lobbyist, City of Hamilton. Dave Woodard, News Anchor with 900 CHML. Sam Routley, PhD Candidate with the Department of Political Science at the University of Western Ontario; Bylines in The Conversation, The National Post and The Hill Times; expertise in how Canadians relate to the Monarchy, Canadian political institutions, political leadership, political culture and Conservatism. Antonia Mantonakis, Professor of Marketing and Consumer Psychology, Brock University. Fred Eisenberger, former Mayor of the City of Hamilton. Shelly Hill, Manager, Indigenous Relations, City of Hamilton. Marvin Ryder, Professor with the DeGroote School of Business at McMaster University. Christian Leuprecht, Professor at both the Royal Military College of Canada and Queen's University, and a Fellow at the Macdonald Laurier Institute. Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto. Saad Salman, Royal Commentator, Founder and Editor of The Royal Watcher (https://royalwatcherblog.com/), Royal Contributor for ELLE Andrea Horwath, Mayor of the City of Hamilton. Host – Scott Thompson Content Producer – William Erskine Technical/Podcast Producer – Tom McKay Podcast Co-Producer – Ben Straughan News Anchor – Jen McQueen Want to keep up with what happened in Hamilton Today? Subscribe to the podcast! https://megaphone.link/CORU8835115919
The Hamilton Today Podcast with Scott Thompson: Car thefts are endemic: what needs to change? Do we need to go back to the key? Auto journalist Lorraine Sommerfeld talks to Scott. Is F1 overtaking NASCAR? Todd Lewis rejoins Scott after many years to talk more. As well, The Welland Canal — a key link in the North American supply chain — has reopened today, following a three-month closure for maintenance. We look at the bonds between Russia and China, following Xi's meeting with Putin. It is all coming up on the Hamilton Today Podcast! Guests: Lorraine Sommerfeld, columnist with Driving.ca and the Hamilton Spectator Todd Lewis, host of Rec Culture TV, NASCAR announcer, ft. in Scouting The Refs & Racin' It Out podcasts. Terence Bowles, President and CEO of the St. Lawrence Seaway Management Corporation. Melissa Haussman, Professor, Department of Political Science at Carleton University. Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto Michael Veall, Professor Economics at McMaster University, Academic Director, Statistics Canada Research Data Centre. Andrew McDougall, Assistant Professor in Canadian Politics and Public Law with the University of Toronto. Dr. Arne Kislenko, Margaret MacMillan Trinity One International Relations Program, Trinity College, University of Toronto; Department of History at Toronto Metropolitan University Scott Radley, Host of the Scott Radley Show and Columnist with the Hamilton Spectator. Host –Scott Thompson Content Producer – William Erskine Technical/Podcast Producer - William Webber Podcast Co-Producer –Ben Straughan News Anchor –David Woodard, Jennifer McQueen Want to keep up with what happened in Hamilton Today? Subscribe to the podcast! https://megaphone.link/CORU8835115919
Our guest today is an award-winning pain specialist with decades of experience helping patients with chronic pain achieve a better quality of life. Dr. Andrea Furlan is a specialist in Physical Medicine and Rehabilitation, an Associate Professor in the Department of Medicine at the University of Toronto, and a Staff Physician and Senior Scientist at the Toronto Rehabilitation Institute. In her new book, 8 Steps to Conquer Chronic Pain: A Doctor's Guide to Lifelong Relief, Dr. Furlan shares science-backed solutions to beat pain that she has seen work in her own practice. So for anyone out there suffering in silence, or for those who have a loved one dealing with chronic pain, this episode is a must-listen! “We all have pain here and there. Now, if this pain happens in a person that has the amygdala super active, they will respond with an exaggerated fear response. And that fear of pain after the injury heals is related to the perpetuation of the pain itself. So that's how the pain transitions from acute to chronic, because the injury heals, but the fear of pain continues.” - Dr. Andrea Furlan What we discuss in this episode: How Dr. Furlan became interested in pain management How opioid addiction starts The difference between acute pain and chronic pain, and how acute pain transitions to chronic pain How emotions affect pain and regulate what we feel physically How you can improve your body's “inner pharmacy” and become more resistant to pain Natural anti-inflammatory recommendations Recommendations to cope with different types of headaches Resources: Dr. Furlan's book: 8 Steps to Conquer Chronic Pain: A Doctor's Guide to Lifelong Relief - https://www.amazon.com/Steps-Conquer-Chronic-Pain-Lifelong/dp/0778807118/ref=sr_1_1?crid=1SOSJNLMMN5C8&keywords=Dr.+Andrea+Furlan&qid=1677820969&s=books&sprefix=dr.+andrea+furlan%2Cstripbooks%2C182&sr=1-1 YouTube channel: https://www.youtube.com/c/DrAndreaFurlan?app=desktop Instagram: https://www.instagram.com/dr.andrea.furlan/?hl=en Facebook: https://www.facebook.com/dr.andrea.furlan/ Dairy-Free Swaps Guide: Easy Anti-Inflammatory Meals, Recipes, and Tips https://switch4good.org/dairy-free-swaps-guide SUPPORT SWITCH4GOOD https://switch4good.org/support-us/ ★☆★ JOIN OUR PRIVATE FACEBOOK GROUP ★☆★ https://www.facebook.com/groups/podcastchat ★☆★ SWITCH4GOOD WEBSITE ★☆★ https://switch4good.org/ ★☆★ ONLINE STORE ★☆★ https://shop.switch4good.org/shop/ ★☆★ FOLLOW US ON INSTAGRAM ★☆★ https://www.instagram.com/Switch4Good/ ★☆★ LIKE US ON FACEBOOK ★☆★ https://www.facebook.com/Switch4Good/ ★☆★ FOLLOW US ON TWITTER ★☆★ https://mobile.twitter.com/Switch4GoodNFT ★☆★ DOWNLOAD THE ABILLION APP ★☆★ https://app.abillion.com/users/switch4good
Secretary McDonough Office U.S. Department of Veterans Affairs Co-Host: Dr ArnoldPanelist: Dr. Fola May - is a Staff Physician at the Veterans Affairs Greater Los Angeles Healthcare System
Dr. Kevin Hopkins has been a Staff Physician in the Department of Family Medicine at the Cleveland Clinic since 2005. Dr. Hopkins also serves as Primary Care Medical Director for Cleveland Clinic Community Care, the Cleveland Clinic's primary care, population health institute. Over the past several years he has become a recognized leader and national speaker in the field of Caregiver burnout and ambulatory practice re-design and transformation. Dr. Hopkins has led the transition of his primary care group to a model of Value-Based Care and is continuing to leverage an advanced team-based care practice model as a vehicle to achieve the goals of population management. He holds an academic appointment with Cleveland Clinic Lerner College of Medicine as a Clinical Assistant Professor in the Department of Family Medicine, teaches within the Cleveland Clinic Family Medicine Residency Program, and is also a faculty instructor for the Cleveland Clinic Global Leadership and Learning Institute. Dr. Hopkins is a Senior Physician Advisor with the Professional Satisfaction and Practice Sustainability Initiative for the American Medical Association (AMA) and has previously served as a physician advisor for Google Health.Thanks for tuning in! Check out more episodes of The Well-Being Connector Podcast at www.forphysicianwellbeing.org/podcast.
The Hamilton Today Podcast with Scott Thompson: Former Mississauga mayor Hazel McCallion has died at the age of 101. Ontario Premier Doug Ford announced her passing in a statement early on Sunday morning, calling her the “true definition of a public servant.” With Ukraine receiving advanced western weapons, air defences are being placed on key buildings in Russia's capital. Canada is not the only Western country facing serious challenges when it comes to military recruitment — but the chief of the defence staff says the issues raise concerns about potential threats to democracy. The World Health Organization has announced that, although COVID-19 still represents a crisis in the world, it is nearing an “inflection point” where higher levels of immunity can lower virus-related deaths. Parliament is Back! What's in store for them? It is all coming up on the Hamilton Today Podcast! Guests: Bonnie Crombie, Mayor of the City of Mississauga. David Adames, CEO of Niagara Parks Commission. Erik Tomas, The Raceline Radio Network Toronto. Matthew Light, Associate professor of criminology and sociological studies, affiliated faculty, centre for European, Russian and Eurasian studies, University of Toronto. Christian Leuprecht, Professor at both the Royal Military College of Canada and Queen's University, and a Fellow at the Macdonald Laurier Institute. Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto. Peter Graefe, Professor of Political Science with McMaster University. Ron Foxcroft, Canadian businessman, Fox40World, creator of the FOX40 whistle, author of 40 Ways of the Fox, CEO of Fluke Transport… former Honorary Colonel with the Argyll Regiment, Chairman of the Argyll Commemorative Fundraising Campaign. Scott Radley, Host of the Scott Radley Show on 900CHML Columnist for the Hamilton Spectator. Host – Scott Thompson Content Producer – William Erskine Technical/Podcast Producer – Tom McKay Podcast Co-Producer – Ben Straughan News Anchor – Diana Weeks, David Woodard Want to keep up with what happened in Hamilton Today? Subscribe to the podcast! https://megaphone.link/CORU8835115919
The Hamilton Today Podcast with Scott Thompson: Just a few days more until Christmas, and the mood in CHML is heating up! Scott is pitting the technical producers against the newsroom on who becomes champion of Christmas songs. More on that right off the top. Boxing day has come early, why are retailers so excited to eject their stock early this year? Retail analyst Bruce Winder joins Scott for that. Justin Bieber is selling his back catalogue, but isn't that usually an older artist move? Alan Cross, of the Ongoing History of New Music, sheds a light on this emerging trend for younger artists. A new COVID variant has reared its head; Dr. Isaac Bogoch has more on that. As well, more on urban boundary expansion in Hamilton and the feds have a plan to bar real estate purchases by non-Canadians. It is all coming up on the Hamilton Today Podcast! Guests: Bruce Winder, Retail Analyst & Author, ‘Retail Before, During & After COVID-19' Alan Cross, Host of the Ongoing History of New Music. Lee Hill, a research coordinator at McMaster University and post-doctoral fellow at McGill; coached swimming at Olympic and national levels in South Africa before coming to Canada; is part of the International Ice Swimming Association; PhD in Exercise Science, specializing in musculoskeletal injuries in swimmers. Rishi Bandhu, Bandhu Law Professional Corporation, the lawyer for the parent group. Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto Mike Collins-Williams, CEO, West End Home Builders Association. Dr. Ian Lee, Associate Professor with the Sprott School of Business at Carleton University. Scott Radley, Host of The Scott Radley Show, Columnist with the Hamilton Spectator. Host – Scott Thompson Content Producer – William Erskine Technical/Podcast Producer - William Webber Podcast Co-Producer – Ben Straughan News Anchors – Dave Woodard & Diana Weeks Want to keep up with what happened in Hamilton Today? Subscribe to the podcast! https://megaphone.link/CORU8835115919
The Hamilton Today Podcast with Scott Thompson: The feds and the provinces are playing a game of hot potato as we try to find out where the buck stops with healthcare. Yesterday's storm came and went and while it is rather ugly out there, Hamilton still got off rather lightly but what is next for this storm? Scott brings on Global News meteorologist Ross Hull for an update. Scott's kids may vow never to live in the US, because the Senate unanimously approved a measure Wednesday night that would ban federal employees from using TikTok on all government devices, a move made out of security concerns over the app and its Chinese-owned parent company ByteDance. Tech journalist Carmi Levy joins Scott to discuss this unprecedented move. It is all coming up on the Hamilton Today Podcast! Guests: Peter Graefe, Professor of Political Science with McMaster University. Ross Hull, Global News Meteorologist. Marvin Ryder, Professor with the DeGroote School of Business at McMaster University. Carmi Levy Technology Analyst & Journalist. Duff Conacher, Co-Founder of Democracy Watch. Elliot Tepper, Emeritus Professor of Political Science with Carleton University. Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto Dr. Frank Clayton, Senior Research Fellow, Centre for Urban Research and Land Development, Toronto Metropolitan University. Scott Radley, Host of The Scott Radley Show, Columnist with the Hamilton Spectator. Host – Scott Thompson Content Producer – William Erskine Technical/Podcast Producer - William Webber Podcast Co-Producer – Ben Straughan News Anchors – Dave Woodard & Diana Weeks Want to keep up with what happened in Hamilton Today? Subscribe to the podcast! https://megaphone.link/CORU8835115919
The Hamilton Today Podcast with Scott Thompson: What role can/should masking play in this flu season? Should flu vaccines be the higher priority? Hamilton-Wentworth District School Board has a temporary masking policy coming on the horizon which students will be able to opt out of. Canada – and other nations around the world – continues to look into the alleged presence of secret “Police Stations” operating on behalf of Xi Jinping's Chinese Communist Party, as well as the overall issue of foreign interference. Blackie and the Rodeo Kings, one of Canada's most esteemed music collectives, celebrated their 25th anniversary and their 11th studio album earlier this year. Now, coming up on Saturday, December 10, Colin Linden, Tom Wilson and Stephen Fearing will be performing at Hamilton's FirstOntario Concert Hall. What do we need to know about this flu season and the viruses spread, alongside COVID-19 and its variants, as well as the spike in RSV? All this and more coming up on Hamilton Today. Guests: Thomas Tenkate, Professor at the School of Occupational & Public Health with Toronto Metropolitan University University. Dawn Danko, Chair, Hamilton-Wentworth District School Board. Sam Cooper, National investigative Global News, author of Wilful Blindness: How a Criminal network of narcos, tycoons and CCP agents infiltrated the West. Jennifer Johnson, Washington correspondent with Global News. Tom Wilson, Mohawk author, visual artist, and musician (LeE HARVeY osMOND, Blackie and the Rodeo Kings, Junkhouse), focus of the new documentary film Beautiful Scars. Sean Simpson, VP of IPSOS Public Affairs. Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto. Michael Veall, Professor Economics at McMaster University, Academic Director, Statistics Canada Research Data Centre. Scott Radley, Host of The Scott Radley Show, and Columnist with your Hamilton Spectator Host – Scott Thompson Content Producer – William Erskine Technical/Podcast Producer – Tom McKay Podcast Co-Producer - Ben Straughan News Anchor – Diana Weeks & Dave Woodard Want to keep up with what happened in Hamilton Today? Subscribe to the podcast! https://megaphone.link/CORU8835115919
The Bill Kelly Show Podcast: Warnings continue to come in across Ontario, as the triple threat of influenza, COVID-19 and RSV continue to slam our hospitals. Is it time to bring back to mask mandate? GUEST: Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto - Canada's low unemployment rate is not sustainable and is contributing to decades-high inflation, Bank of Canada governor Tiff Macklem said during a speech in downtown Toronto Thursday. Speaking before students and researchers at Toronto Metropolitan University, the governor said the Canadian labour market needs to be rebalanced to stabilize inflation. GUEST: Moshe Lander, Senior Economics Lecturer, Concordia University - Topics Include: Ontario government introduce grade 6 Holacaust education Ontario education strike Ontario Greenbelt proposal to cut land for hmes And more…. GUEST: John Best, Publisher of The Bay Observer - Canadians are buying less expensive food, stockpiling food and even eating less to cope with food prices as inflation soars, according to a new survey. The survey, conducted by Nanos Research on behalf of CTV News, asked more than 1,000 Canadians if their household had used a cost-saving option in the past month in response to the price of food. GUEST: Janet Music, Research Program Coordinator at the Agri-Food Analytics Lab
Mackenzie Moir, Policy Analyst at the Fraser Institute, joins the show to break down their latest analysis ranking countries with universal health care. Canada is not doing well..Dr. Lennox Huang - Chief Medical Officer and Staff Physician in the Critical Care Unit at SickKids joins The Rush to outline the issues he's seeing as Ontario hospitals deal with a surge of respiratory diseases.
Parkinson's disease is the fastest growing neurological disorder and has shown an alarming increase in prevalence worldwide. Fortunately, there are a number of new innovative developments that help us treat this condition. Today's guest is Dr. Shivam Om Mittal, an expert in the treatment of Parkinson's disease and a Staff Physician in the Neurological Institute at Cleveland Clinic Abu Dhabi.
This episode of Butts & Guts features Dr. Xiangling Wang, a Staff Physician in Cleveland Clinic's Genomic Medicine Institute in the Department of Kidney Medicine. She discusses genetic testing and kidney disease management with the podcast's host, Dr. Scott Steele. Listen and learn more about genetic testing, who should consider having a genetic evaluation for kidney disease, and the type of care you can expect from Dr. Wang and the renal genetics program team at Cleveland Clinic.
In this episode we will be discussing a recent paper published in CHEST entitled Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline with lead author Dr Jim Douketis. Dr. Douketis is Staff Physician in General Internal Medicine and Clinical Thromboembolism at St. Joseph's Healthcare Hamilton. He is a Professor of Medicine and holds the David Braley-Nancy Gordon Chair in Thromboembolic Disease at McMaster University. Dr Douketis is past-president of Thrombosis Canada.Dr. Douketis' research interests include perioperative antithrombotic therapy, prognosis of patients with venous thromboembolism, hormonal therapy and thrombosis, prevention of venous thrombosis in medical patients, and clinical practice guideline development.Dr. Douketis is a Fellow of the Canadian Academy of Health Science, Past-President of Thrombosis Canada, Associate Editor of McMaster Textbook of Internal Medicine, Editor-in-Chief of Canadian Journal of General Internal Medicine, Deputy Editor of Annals of Internal Medicine ACP Journal Club, and Associate Editor of Thrombosis and Haemostasis. He has over 350 peer-reviewed publications.Follow us on Twitter;Thrombosis Canada: @ThrombosisCanReference:Douketis JD, Spyropoulos AC, Murad MH, Arcelus JI, Dager WE, Dunn AS, Fargo RA, Levy JH, Samama CM, Shah SH, Sherwood MW. Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline. Chest. 2022 Aug 11.Support the showhttps://thrombosiscanada.caTake a look at our healthcare professional and patient resources, videos and publications on thrombosis from the expert members of Thrombosis Canada
Dr. Miranda Lim is a neurologist with board certification in Sleep Medicine. She is an Associate Professor in Neurology with secondary appointments in Behavioral Neuroscience and Medicine in the OHSU School of Medicine, as well as an Affiliate faculty for our Institute, Oregon Institute of Occupational Health Sciences. Miranda also has a joint appointment as a Staff Physician and Research Investigator at the Veterans Affairs Portland Health Care System. Dr. Lim's research program, Sleep & Health Applied Research Program (SHARP), focuses on understanding the function of sleep in neurological disorders across the lifespan. Some examples include autism spectrum disorder, traumatic brain injury (TBI), posttraumatic stress disorder (PTSD), and aging/neurodegenerative disease. As a translational neuroscientist, her research program is known for its bidirectional, translational research spanning preclinical (rodent) and human studies. Methods used include conducting sleep studies (such as sleep manipulations and sleep interventions), quantitative analyses of sleep, implementing non-obtrusive long-term wearables (e.g., actigraphy, mattress sensors), and using machine learning to quantify sleep. Over the years, Miranda's research has been published in high-impact journals Nature, Journal of Clinical Investigation, Science Translational Medicine, and Science Advances, as well as support from many federal and foundation sources, such as the National Institutes of Health, Department of Defense, American Sleep Foundation, Center for Aging and Technology, Portland VA Research Foundation, and more! Learn more about Dr. Lim's research: Dr. Lim's Research featured on GeekWire: https://www.geekwire.com/2021/neurosciences-startup-gets-defense-dept-funds-test-headband-improve-sleep-clean-brain OPB: https://www.opb.org/article/2022/06/01/the-science-of-sleep-pacific-northwest-researchers-explore-secrets-of-a-good-nights-rest OHSU News: Physician-scientist focuses on a good night's sleep https://news.ohsu.edu/2019/05/13/ohsu-physician-scientist-focuses-on-a-good-nights-sleep OHSU News: Rare sleep disorder common among veterans with PTSD https://news.ohsu.edu/2019/10/10/rare-sleep-disorder-common-among-veterans-with-ptsd VA Career Development Awardee Profiles, Miranda Lim, M.D., Ph.D. https://www.research.va.gov/about/awards/cda/default.cfm A Local Neurologist Thinks a Baby's Dream State May Affect Their Adult Life https://www.pdxmonthly.com/health-and-wellness/2019/12/a-local-neurologist-thinks-a-baby-s-dream-state-may-affect-their-adult-life OHSU doctor says we're starved for sleep but hope isn't lost https://www.columbian.com/news/2021/jan/10/ohsu-doctor-says-were-starved-for-sleep-but-hope-isnt-lost VA Blog: Studying sleep problems that affect Veterans https://blogs.va.gov/VAntage/84912/studying-sleep-problems-affect-veterans Save-the-date for Oregon Healthy Workforce Center's 2022 Summer Institute on Tuesday, July 19, 2022 on "Total Worker Health® approaches in industry and academia: Key elements and implementation." Learn more here: https://www.ohsu.edu/oregon-healthy-workforce-center/summer-institute-occupational-health-psychology-total-worker --- Episode information: What's Work Got to Do With Brain Cleansing Technology? Guest: Dr. Miranda Lim, M.D., Ph.D. Hosted and Edited by: Helen Schuckers, MPH Produced by: Helen Schuckers, MPH and Anjali Rameshbabu, PhD Music by: Sam Greenspan, MPH Connect with us Oregon Institute of Occupational Health Sciences and Oregon Healthy Workforce Center on social media: Twitter: twitter.com/OHSUOccHealth Facebook: www.facebook.com/occhealthsci.ohsu LinkedIn: www.linkedin.com/company/occhealthsci Blog: blogs.ohsu.edu/occupational-health-sciences Community feedback is important to us. If you love our podcast and want to further support our podcast, please consider leaving us a 5-star review. Thank you!
Sustainable Development Goal 16: Peace, Justice, and Strong Institutions focuses on promoting peaceful and inclusive societies for sustainable development, providing access to justice for all and building effective, accountable, and inclusive institutions at all levels.Dr. Ross Upshur is currently the Dalla Lana Chair in Clinical Public Health and Head of the Division of Clinical Public Health at the Dalla Lana School of Public Health, Scientific Director, Bridgepoint Collaboratory for Research and Innovation and Associate Director of the Lunenfeld Tanenbaum Research Institute, Sinai Health. At the University of Toronto, he is a Professor in the Dalla Lana School of Public Health and the Department of Family and Community Medicine, affiliate member of the Institute for the History and Philosophy of Science and Technology, Member of the Centre for Environment and Adjunct Senior Scientist at the Institute for Clinical Evaluative Sciences. He is a Staff Physician at Bridgepoint Active Healthcare, Sinai Health. In 2015, he was named one of the Top 20 Pioneers in Family Medicine Research in Canada by the College of Family Physicians of Canada and was a Tier 2 Canada Research Chair from 2005-2015. He is an elected Fellow of the Hastings Center and the Canadian Academy of Health Sciences. During COVID-19 he has served as the co-Chair of the WHO Ethics and COVID-19 Working group and is a member of the WHO ACTA Ethics and Governance Working Group.Rushay Naik is an MSc student in Health Policy & Global Health at the University of Toronto. His research centres on health service delivery in conflict-affected states, and has conducted fieldwork for research initiatives in Greece, Mongolia, and Switzerland. Rushay has held research fellowships at UofT's School of Cities, at the Center for the Study of the Presidency & the Congress in Washington, D.C., and at the University of Oxford's COVID-19 Government Response Tracker. Rushay previously worked for Health Canada's Climate Change and Innovation Bureau, and is now an incoming intern to the Health Division at the OECD in Paris. CREDITS: This podcast is co-hosted by Dr. Erica Di Ruggiero, Director of the Centre for Global Health, and Ophelia Michaelides, Manager of the Centre for Global Health, at the DLSPH, U of T, and produced by Elizabeth Loftus. Audio editing is by Sylvia Lorico. Music is produced by Julien Fortier and Patrick May. It is made with the support of the School of Cities at U of T.
In this episode we discuss a recent paper published jointly in The American Journal of Gastroenterology and the Journal of the Canadian Association of Gastroenterology entitled American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline: Management of Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Periendoscopic Period and co-authored by a Canada – United States team of experts.The interview with co-authors Dr Alan Barkun and Dr Jim Douketis covers the rationale for the new guidelines as well as the implications for clinicians. Dr Barkun is Professor of Medicine in the Division of Gastroenterology at McGill University and the McGill University Health Centre, Montréal, Canada. He is current holder of the DG Kinnear Chair in Gastroenterology at McGill University. Recipient of many national and international awards, Dr. Barkun has published over 400 peer-reviewed articles and abstracts and has given over 600 international presentations on emerging digestive endoscopic technologies, with an emphasis on methodological, clinical and cost-effectiveness trials of treatments for upper gastrointestinal bleeding (UGIB), bilio-pancreatic diseases and colorectal cancer screening. He is also the current President of the colorectal Cancer screening implementation committee for the province of Quebec. ANDDr. Douketis is Staff Physician in General Internal Medicine and Clinical Thromboembolism at St. Joseph's Healthcare Hamilton. He is a Professor of Medicine and holds the David Braley-Nancy Gordon Chair in Thromboembolic Disease at McMaster University. Dr Douketis is past-president of Thrombosis Canada.Dr. Douketis' research interests include perioperative antithrombotic therapy, prognosis of patients with venous thromboembolism, hormonal therapy and thrombosis, prevention of venous thrombosis in medical patients, and clinical practice guideline development.Dr. Douketis is a Fellow of the Canadian Academy of Health Science, Associate Editor of McMaster Textbook of Internal Medicine, Editor-in-Chief of Canadian Journal of General Internal Medicine, Deputy Editor of Annals of Internal Medicine ACP Journal Club, and Associate Editor of Thrombosis and Haemostasis. He has over 350 peer-reviewed publications.Related Thrombosis Canada Resources:DOAC Bleeding Management Clinical Guide: [LINK]DOAC Perioperative Management Clinical Guide: [LINK]Perioperative Anticoagulant Algorithm: [LINK]Follow us on Twitter: @thrombosiscanReference:Abraham NS, Barkun AN, Sauer BG, Douketis J, Laine L, Noseworthy PA, Telford JJ, Leontiadis GI. American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline: Management of Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Periendoscopic Period. Journal of the Canadian Association of Gastroenterology. 2022 Apr;5(2):100-1Support the showhttps://thrombosiscanada.caTake a look at our healthcare professional and patient resources, videos and publications on thrombosis from the expert members of Thrombosis Canada
In this podcast episode, host Dr. Steven H. Linder talks with three other expert physicians who are leaders in the fight against the opioid epidemic: Dr. Casey Grover, Dr. Don Stader, and Dr. Scott Weiner. The panel explores the power of naloxone, the emergency intervention that has saved countless people after accidental overdose with fentanyl, the illicit drug now appearing in pill form and in illegal drugs of all kinds. The physicians give a moving inside look at the actual situation on the front lines, as healthcare professionals and communities join forces to save their loved ones. With opioid-related deaths at an all-time high in 2022, the panelists explore how we can make a difference, whether by carrying naloxone personally, raising awareness of fentanyl's dangers, or advocating for much-needed investment in addiction medicine. The podcast begins with a 4 minute introduction and background to the subject, followed by the panel discussion at 4:00. Featuring: Steven H. Linder, MD, FCCP, American Board of Internal Medicine, American Board of Pulmonary Medicine, Staff Physician, VA Medical Center Palo Alto, California Casey Grover, MD, FACEP, Chair of the Division of Emergency Medicine, Community Hospital of the Monterey Peninsula and Physician Champion of the Monterey County Prescribe Safe Initiative. Don Stader, MD, FACEP, Founder & President, Stader Opioid Consultants and Chair of the Colorado Naloxone Project. Physician, Swedish Medical Center and Lincoln Health in Colorado. Scott Weiner, MD, MPH, Director, Brigham Comprehensive Opioid Response and Education Program, Brigham Women's Hospital
The Hamilton Today Podcast with Scott Thompson... Dr. Keiran Moore appeared on our screens today for his first Ontario COVID-19 update in almost a month. He affirmed that we are in wave 6 but did not announce plans to reinstate masking, just strongly recommend that we continue it. Relations between Frito-Lay and Loblaws have come to an agreement and relations are decidedly less salty. Tiger Woods made his return to the Masters. What are the takeaways from his performance, and what might be on the horizon for the gold legend? What role does the media – and the technology that the media uses – play in bringing the humanity of modern wars, like Russia's viscous invasion of Ukraine, to the eyes of the world and how does that affect us? Now it looks like Elon Musk will not be joining the board of directors for Twitter. Good idea, bad idea, whose idea? We welcome Dr. Frank Calyton back to the show to discuss the housing – and building issues – in Ontario. Guests: Elissa Freeman, PR and Pop Culture Expert Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto Dr. Ian Lee, Associate Professor with the Sprott School of Business at Carleton University Jason Logan, editor of SCOREGolf Magazine Jeffrey Dvorkin, Senior Fellow at Massey College, Former Director of Journalism at the University of Toronto-Scarborough and author of Trusting the News in a Digital Age Daniel Ives, Managing Director of Equity Research with Wedbush Investments Dr. Frank Clayton, Senior Research Fellow, Centre for Urban Research and Land Development, Ryerson University Scott Radley, Host of The Scott Radley Show, Columnist with the Hamilton Spectator Host - Scott Thompson Content Producer – William Erskine Technical/Podcast Producer - Ben Straughan News Anchors – Diana Weeks, Dave Woodard Want to keep up with what happened in Hamilton Today? Subscribe to the podcast! https://omny.fm/shows/scott-thompson-show See omnystudio.com/listener for privacy information.
In this episode, we're excited to learn from Vik Bakhru, Chief Health Officer at Circulo Health. Circulo is building the Medicaid insurance company of the future to provide tech-enabled, world-class care to the nation's most underserved populations. Vik is also currently a member of the clinical advisory board at Bright Health and a practicing Staff Physician at UCSF Medical Center. Prior to Circulo, Vik was the Chief Operating Officer and Chief Financial Officer at SameSky Health (formerly Consejosano) for almost 4.5 years and COO of First Opinion. In February 2021, Circulo launched out of stealth at $50M led by Drive Capital, General Catalyst, Oak HC/FT and SVB Capital.
The Hamilton Today Podcast with Scott Thompson... With press conferences all over and turmoil galore, Scott takes a trip to the sunny state of Florida to catch up with an old friend. In the midst of everything happening this week, there was word that Ontario is looking at doing away with license plate sticker renewal fees. What is up with that? Ontario Premier Doug Ford announced today that the province is intending on the removing various restrictions in addition to announcing that Ontario is now officially in a state of emergency. A new Ipsos poll shows a significant number of Canadians sympathize with the concerns held by protestors which, on the surface, are the primary reasons for the initial protest in Ottawa -- but they do not support the methods such as blocking borders that are crucial to trade with the U.S., and disruptive occupation of the nation's capital.The blockades interrupting trade at the Ambassador Bridge Canada-U.S. border are lending credence to champions of Buy American policies. What could come of this? What kind of political response has come about from the occupation of Ottawa and blockades at border crossings? How much damage – beyond the economic effects – have the border blockades and the occupation of Ottawa done to Canada's relationship with the United States? Researchers at McMaster University say recent animal studies have proven a pair of inhaled vaccines are effective against the original coronavirus that causes COVID-19 and variants of concern. Are we going to see the Superbowl end up eclipsing the Olympics and speaking of the Olympics, how healthy are the viewership numbers? Guests: Doc Halen, retired morning show host, Wordle enthusiast, Scott's Florida Informant Lorraine Sommerfeld, Auto Writer with Post Media, Motherlode column in the Hamilton Spec and Host of the Lemon Aid Car Show on RogersTV Sabrina Nanji, Founder of the Queen's Park Observer Elissa Freeman, PR and Pop Culture Expert Darrell Bricker, CEO of IPSOS Polling Charles Sox, Associate Dean, Professor of Operations and Business Analytics, Associate Dean of Impact and Partnerships for the University of Cincinnati Carl H. Lindner College of Business Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto Daniel Perry, Consultant, Summa Strategies Robert Bothwell, Professor, Department of Canadian History, Munk School of Global Affairs, Professor, Department of International Relations, Munk School of Global Affairs, University of Toronto Sam Afkhami. Post Doctoral Researcher with McMaster University, co-author of the recent study on aerosolized vaccination Bill Brioux, television critic and author See omnystudio.com/listener for privacy information.
The middle east is not only an area of diversity and brisk transformations, it is also a region where cardiovascular diseases are rampant. Traditional risk factors for atherosclerotic disease are more prevalent than most regions around the globe; In the middle east, one in five will have either diabetes, obesity, hypertension, or smoking. Dyslipidemia, which is a recognized cause of atherosclerosis, is even more common. That's why I decided to shed some light on Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East: 2021 update published this month in Atherosclerosis journal.https://doi.org/10.1016/j.atherosclerosis.2021.11.022And there is no better than Dr Hani Sabbour to interview on this indispensable publication. Dr. Sabbour is a colleague and friend. He has six American Board Certifications: Internal Medicine, General cardiology, Electrophysiology, Advanced Heart failure and Transplant Cardiology, Echocardiography and Nuclear Cardiology. He is currently Staff Physician in Cleveland Clinic Abu Dhabi. He is a co-principal investigator in the Gulf Familial Hyperlipidemia Registry and naturally, he is one of the authors of this consensus clinical recommendation.
The James Webb Space Telescope is set to be the successor to the famous Hubble Space Telescope, continuing its legacy of peering deeper into the cosmos but what does the world's most expensive telescope mean for us? Former U.S. President Donald Trump was booed by his own supporters after announcing that he had received his COVID-19 Booster Vaccine. As funny as it may seem from some points of view, what does it mean for the U.S. if some of the fervent fans of Trump start to feel like he has betrayed their values? Doug Ford is taking heat because of the vaccine rollout and pandemic response and it's coming from those both craving vaccines and opposing them. Dr. Isaac Bogoch joins the show for a bit of a retrospective on the pandemic in Ontario. The Federal Housing Minister, Ahmed Hussen, told Reuters that he supports cities implementing density measures, as well as banning foreign home buyers, to control the housing crunch. Would that solve the housing crisis? And politically speaking, how is the Federal government handling the pandemic? Guests: Paul Delaney, the Allan I. Carswell Chair for the Public Understanding of Astronomy, University Professor (Teaching Stream) York University, Toronto Brian J. Karem, Political Analyst for CNN, White House Reporter and host of ‘Just Ask the Question' Podcast Michael Taube, Troy Media Syndicated Columnist, Washington Times contributor, you can find his writings all over, and Former Speech Writer for Stephen Harper Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto Ian Lee, Associate Professor with the Sprott School of Business at Carleton University Henry Jacek. Professor of Political Science, McMaster University Scott Radley, Drake's biggest fan, Host of The Scott Radley Show, Columnist with the Hamilton Spectator Diana Weeks, anchor with Global News Radio 900 CHML William P. Erskine, producer with Global News Radio 900 CHML Host - Scott Thompson Content/Technical/Podcast Producer - William P. Erskine Podcast Co-Producer - Ben Straughan News Anchor - Diana Weeks Want to keep up with what happened in Hamilton Today? Subscribe to the podcast! https://omny.fm/shows/scott-thompson-show See omnystudio.com/listener for privacy information.
Our Youth's Mental HealthA topic that goes under the radar more often than it should, is youth mental health.Here with us today to dive into this topic is Dr. Shahana Alibhai, Family Physician and Staff Physician at the Foundry Abbotsford.Key Takeaways from Dr. Fedrick's 1-on-1 with the Dr.:• Hear about Dr. Shahana's background and the work that she does• Find out what some of the most common disorders are that Dr. Shahana sees • Learn how the doctor addresses depression with her patients• Hear how Dr. Shahana teaches her patients to train their minds• Find out why self care is so importantAll of this and more, on this episode of Calm, Cool and Connected.Learn more about Doctor Shahana Alibhai: www.drshahana.comConnect with Dr. Shahana on IG: http://www.instagram.com/thedrshahana.comFor more information on Dr. Elizabeth Fedrick, visit her website https:// www.evolvecounselingaz.com/dr-elizabeth-fedrick.Connect with Dr, Fedrick on Instagram: https://www.instagram.com/drelizabethfedrick/Have a question you'd like answered on the show? Leave us a voicemail here: https://www.speakpipe.com/CalmCoolConnectedFor more great Calm, Cool and Connected content, don't forget to subscribe to the podcast on Apple Podcasts, Google Podcasts, Overcast, Spotify, and all the popular podcasting platforms. (RSS) https://3cstvshow.buzzsprout.comAlready subscribed? Please take a moment to rate and review the podcast so that we can reach as many people that need the help as we can: https://3cstvshow.buzzsprout.com DISCLAIMER: THE CONSULTATIONS OR INTERACTIONS OFFERED ARE NOT MENTAL HEALTH THERAPY. THE CONSULTATION IS FOR EDUCATIONAL PURPOSES ONLY AND NOT STRUCTURED IN A WAY TO PROVIDE MENTAL HEALTH COUNSELING/PSYCHOTHERAPY/THERAPY/ DIAGNOSING OF ANY KIND. YOU UNDERSTAND THAT CALM COOL AND CONNECTED IS NOT PROVIDING INFORMATION AS YOUR TREATING MENTAL HEALTH COUNSELOR, PHYSICIAN, ATTORNEY, LEGAL COUNSEL, EMPLOYER, MEDICAL PROFESSIONAL. We offer no guarantees or promise of results from event nor assume liability for any information provided.
The Tim Hortons collaboration with Justin Bieber is continuing from having his own line of Timbits to fanny packs and totes but are they going about it the right way or are there things that can be done in a better way? Those planning on visiting the US won't have to take a PCR test to return to Canada so long as their trip will take less than 72-hours, what does Dr. Isaac Bogoch think of this? The Three Amigos summit began today but what will the leaders of Canada, US & Mexico actually be talking about? What's Doug Ford's plan to make Ontario a major player in the world of electric vehicle manufacturing? The Toronto teacher who wore blackface as a part of their Halloween costume has been fired but the exact same thing happened to Justin Trudeau three times and yet he's managed to get by seemingly without repercussion. Flooding in BC has caused the supply chain to be strained even further especially due to the complications its caused with the Port of Vancouver, the only Canadian port that takes in shipments from China. What does Dr. Thomas Tenkate think of the occupational & public health issues that stem from Ontario's plans to increase the accessibility to COVID-19 testing? And Calgary-based Enbridge Inc. has scored a key victory in the Lin 5 saga following a Michigan judge's rejection of a bid from the state attorney to have the issue thrown out of federal court. Guests: Elissa Freeman, PR and Pop Culture Expert Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto Reggie Cecchini, Washington Correspondent for Global News Marvin Ryder, Professor with the DeGroote School of Business at McMaster University Dr. Liam Midzain-Gobin, Assistant Professor, Political Science with Brock University, whose research focuses on the production and continual remaking of settler coloniality, and Indigenous governance practices Dr. Gordon Houlden, Director of the China Institute and Professor of Political Science with the University of Alberta Dr. Thomas Tenkate, Professor at the School of Occupational & Public Health with Ryerson University Dan McTeague, President of Canadians for AffordableEnergy, Former Liberal MP See omnystudio.com/listener for privacy information.
The Hamilton Today Podcast with Scott Thompson What has Facebook's impact on people and society-at-large been? Has it knowingly been a negative influence? Why is the price of oil and gasoline set to have a big surge? How can we ensure this Thanksgiving is a safe Thanksgiving? Did Trudeau's apology truly make up for what he did wrong? What kind of economic impact will come to the US as a result of the decision to keep the border closed to Canadians? And William Shatner is going to space! It's all being talked about in Hamilton today here, on Hamilton Today. Guests: Paul Delaney, the Allan I. Carswell Chair for the Public Understanding of Astronomy, University Professor (Teaching Stream) York University, Toronto David Soberman, Canadian National Chair in Strategic Marketing, Rotman School of Management, University of Toronto Michael Manjuris, Professor and Chair, Global Management Studies at Ryerson University Ted Rogers School of Business Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto Ian Lee, Associate Professor with the Sprott School of Business at Carleton University Lisa Polewski, Anchor & Reporter with Global News Radio 900 CHML Ted Michaels, Anchor with Global News Radio 900 CHML & Host of the Health & Wellness Show, Scott Radley, Host of The Scott Radley Show, Columnist with the Hamilton Spectator Host - Scott Thompson Content/Technical Producer - William P. Erskine Podcast Producer - Ben Straughan and William P. Erskine News Anchors - Lisa Polewski and Ted Michaels Want to keep up with what happened in Hamilton Today? Subscribe to the podcast! https://omny.fm/shows/scott-thompson-show See omnystudio.com/listener for privacy information.
The Hamilton Today Podcast with Scott Thompson The Prime Minister was avoiding the press while on vacation during yesterday's inaugural Truth and Reconciliation Day, and Scott has opinions! We have the latest with the discussion between the Ontario government and Ontario's Optometrists. Dr. Isaac Bogoch chats with Scott about the choice to recommend Pfizer over Moderna, how natural immunity doesn't replace vaccination and how less than half of kids turning 12 this year are vaccinated. Global's Carolyn Davis gives us a look inside the Moderna facility. And more on the Nygard case, SCOC upholding Ford's TO city council decision, and a drop in from Scott Radley. If you want to know more about the music that is featured on the live show, make sure to tune in from 3:00 - 6:00 est, every weekday on 900 CHML or streaming on https://globalnews.ca/radio/900chml/ Guests: Dr. Sheldon Salaba, President of the Ontario Association of Optometrists. Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto Carolyn Jarvis, Chief Investigative Journalist, Global News. Joseph Neuberger, Criminal Lawyer with Neuberger & Partners LLP. Jay Goldberg, Interim CTF Ontario Director Scott Radley. Host of The Scott Radley Show, Columnist with the Hamilton Spectator Diana Weeks, anchor with Global News Radio 900 CHML Ted Michaels, anchor with Global News Radio 900 CHML William Webber, Technical Producer with 900 CHML Scott Radley, Host of The Scott Radley Show, Columnist with the Hamilton Spectator Host - Scott Thompson Technical/Podcast Producer - William P. Erskine News Anchors - Diana Weeks, Ted Michaels Want to keep up with what happened in Hamilton Today? Subscribe to the podcast! https://omny.fm/shows/scott-thompson-show See omnystudio.com/listener for privacy information.
In this episode of AFSPA Talks, COO Kyle Longton brings us through a discussion of chronic pain management with Hinge Health's Chief Medical Officer, Dr. Jeff Kraus. The two discuss chronic pain, the affects of working from home, how chronic pain relates to one's mental wellness, and more. Dr. Jeff Krauss graduated from Harvard College, earned his Medical degree from the University of California San Francisco School of Medicine, and completed his residency in Physical Medicine & Rehabilitation at Stanford University. On top of Dr. Krauss' full-time role at Hinge Health, he is also a Clinical Assistant Professor at Stanford in the Department of Orthopedics, and continues to practice as a part-time Staff Physician at the VA Palo Alto Health Care System.
Lt. Col. Rob Suffner, Staff Physician at Mon Health Stonewall Jackson Memorial Hospital and with the 811th Hospital Center joins the show from Kuwait to discuss his role in taking care of Afghan refugees. Plus, former WV House Majority Leader Rick Staton discusses the Manchin compromise voting rights bill.
The Scott Thompson Show Podcast The past few weeks have afforded us a number of distractions from the ongoing COVID-19 pandemic... but even with vaccines in arms, reopened provinces and preparations for a return to in-class school taking place, we are already in Canada's Fourth Wave and it is being driven by the Delta Variant. Guest: Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto - The Taliban has returned to power in Afghanistan, Canada says it has flown it final evacuation flight out of Kabul airport, the U.S. is sticking to its deadline of being out of the country by August 31, and ISIS-K is reportedly responsible for yesterday's attack outside of the Kabul airport. Guest: Stephen M. Saideman, Norman Paterson School of International Affairs, Carleton Universtiy; Director, Canadian Defence and Security Network, Co-Host of the Battle Rhythm Podcast - You might have expected indigenous relations to be a dominant part of the election campaign but that has not seemed to be the case, so far. Meanwhile, many people have begun to reassess what they took for granted about Canada and its history, finally listening to what members of indigenous communities have been telling us for decades. Guest: Dr. Liam Midzain-Gobin, Assistant Professor, Political Science with Brock University, whose research focuses on the production and continual remaking of settler coloniality, and Indigenous governance practices - New Ipsos polling, conducted exclusively for Global News, shows NDP Leader Jagmeet Singh is the most likable of the federal party leaders as Liberal Leader Justin Trudeau's popularity sinks during this election campaign. Guest: Sean Simpson, Vice President of Ipsos - Where is Dr. Teresa Tam? The Federal COVID-19 briefing has been paused during the election. Was that a good call? Scott gets input on this and the past week of the campaign, from Tim Powers! Guest: Tim Powers, Chairman of Summa Strategies and Managing Director of Abacus Data Subscribe to the Scott Thompson Show wherever you find your favourite podcasts, keep up with the big stories developing in Hamilton, Ontario and across Canada: https://curiouscast.ca/podcast/189/the-scott-thompson-show/ Host - Scott Thompson Content/Technical/Podcast Producer - William P. Erskine See omnystudio.com/listener for privacy information.
In this episode, we discuss: What is a concussion? 1:07Is a concussion a brain bruise? 2:10 How common are concussions? 2:26What are common ways to get a concussion? 2:54What are the symptoms of concussions? 3:20What are the signs of something more serious? 4:45What should I do if I have any worrisome symptoms? 5:35What should I tell my doctor about my concussion? 5:49How long do symptoms usually last? 6:18What happens if my symptoms persist? 6:39What causes persistent symptoms? 6:57What symptoms of a concussion can last longer? 7:56How do you manage persistent symptoms? 8:22Do I need a MRI or CT scan for my concussion? 8:52How do you treat the symptoms of a concussion? 10:03How long should I rest after having a concussion? 10:43When can I return to school/work? 11:15When can I return to playing sports? 12:46What about screen time and exercise with a concussion? 13:46What is CTE? 14:39What other resources do you recommend? 15:22Return to work protocol: https://parachute.ca/wp-content/uploads/2020/03/Concussion-ReturnToWork-UA.pdfReturn to school protocol: https://parachute.ca/wp-content/uploads/2019/06/Return-to-School-Strategy.pdfReturn to sport protocol: https://parachute.ca/wp-content/uploads/2019/06/Return-to-Sport-Strategy.pdfDr. Mike Evan's Youtube videos: https://www.youtube.com/watch?v=zCCD52Pty4A&t=9s and https://www.youtube.com/watch?v=_55YmblG9YM&t=13sParachute Canada: https://parachute.ca/en/injury-topic/concussion/Email: thedoctordictionary@gmail.comTwitter: @TheDrDictionaryPeer reviewed by Dr. TJ Lou, Family Physician and Staff Physician at WSIB OntarioOriginal music by Nicholas and John BragagnoloDISCLAIMER: This podcast isnt meant to be a replacement for a traditional doctor's appointment, nor is it meant to be providing medical advice. Rather, it is meant to supplement your doctor's visit and explain why your doctor asked what they asked, and help explain the diagnosis and common treatment plans.Doctors often have very different styles and approaches to a patient and their diagnosis. If we discuss a question or treatment plan that your doctor didnt mention, that doesn't mean that they are a bad doctor. This could represent a difference in practice style, or the fact that your doctor knows you better than we do, and has created a treatment plan that better fits your lifestyle. In case of emergency, please go to your local emergency department.
Dr. Ettien was born in Chattanooga and attended the University of the South at Sewanee. Following graduation he accepted a commission in the U.S. Air Force and was rated as an aerial Navigator. Following a tour of duty in the Strategic Air Command, he received his M.D. degree from the Medical College of Georgia, where he was admitted to the Alpha Omega Alpha Honor Society and served as Editor of the student newspaper and as President of the Senior Class. He was also awarded the Mosby Scholarship Award. His postgraduate training was taken at Vanderbilt and the Medical College of Georgia. Following two years of private practice in North Carolina he accepted the position of Associate Professor of Surgery at the Medical College of Georgia. He was subsequently recruited to the Diagnostic Clinic in Largo, Florida, and served as Chairman of the Cancer Control Committee and was the Cancer Liaison Physician to the American College of Surgeons Committee on Cancer for 27 years. Dr. Ettien transitioned to Nashville, TN where he built a Surgical Clinic at TriStar Southern Hills Medical Center (2006-2015) at the request of the hospital. He also served as Chief of Surgery, Chief of Staff, and as a member of the Medical Executive Committee as well as a member of the Board of Trustees. In 2006 he was asked to assume the position of Medical Director of the Southern Hills Wound Care Center. He was subsequently asked to become the first Medical Director of the new TriStar Division Wound and Vascular Services Program (2015-2020.) In addition, he also served as the Medical Director for Integumetrix where he provided physician oversight and direction for the advanced wound care Nurse Practitioners under the American Medical Association (AMA) guidelines. Dr. Ettien is certified by the American Board of Surgery (ABS) in addition to being a Senior Fellow of the American College of Surgeons (ACS), a Fellow of the International College of Surgeons, a member of the Society of Surgery of the Alimentary Tract (SSAT), a Senior Member of the Association for Academic Surgery (AAS) as well as many other surgical organizations. He also served as Editorial Advisor for “Resident and Staff Physician.” In 1982 he became a member of the Undersea Medical Society (UMS) which later became the Undersea and Hyperbaric Medical Society (UHMS). He brings extensive knowledge and expertise with surgical and medical patients with complex wounds and is knowledgeable in the latest wound care technology. Having enjoyed many hours of flying after receiving his Commercial Pilot Rating in 1980 and navigating the ocean floor as a certified SCUBA diver, today, Dr. Ettien spends his off hours as a master model ship builder and is an avid golfer. He and his wife reside in Nashville, TN. Unlock Bonus content and get the shows early on our Patreon Follow us or Subscribe: Apple Podcasts | Google Podcasts | Stitcher | Amazon | Spotify Have you ever considered a different way of practicing medicine? Whether you are burned out, need a change of pace, or are looking to supplement your income, locum tenens might be the solution for you. Not sure where to start? Locumstory.com is the place where you can get real, unbiased answers to your questions. They answer basic questions like, “What is locum tenens?”, to more complex questions about pay ranges, taxes, various specialties, and how locum tenens can work for you. Go to locumstory.com OR doctorpodcastnetwork.com/locumstory and get the answers. --- Show notes at https://rxforsuccesspodcast.com/56 Report-out with comments or feedback at https://rxforsuccesspodcast.com/report Music by Ryan Jones. Find Ryan on Instagram at _ryjones_, Contact Ryan at ryjonesofficial@gmail.com
Livehealthy editor Ann Marie McQueen chats with Dr Dima Quraini, a staff physician at Cleveland Clinic Abu Dhabi’s Heart and Vascular Institute, about supplements and statins, what you really need to do to keep your heart healthy, and what happens to our risk of cardiovascular disease – particularly among women – if we don't.
Wellness Wednesday Summer Break Anxiety Source: https://www.thewholedancer.com/summer-break-anxiety/ Author: Jessie Fraizer Jessie trained at The Rock School West and later the Rock School in Philadelphia. She has attended summer intensives at Nashville Ballet, Orlando Ballet, Pittsburgh Ballet Theater, and BalletX. Jessie has danced with companies in the Philadelphia and New York areas including: BalletFleming, Ballet 180, Dance del Bello, Ballet des Ameriques, Benjamin Briones Ballet, and Axons Dance Theater. Jessie holds a BA in Writing for the Media and Journalism from UMass Amherst. While dancing, she wrote grants and press materials for companies she performed with. She was a content contributor for The Whole Dancer for two years. She now works in arts development, working with American Ballet Theatre, The Rock School, and New York Live Arts. The Whole Dancer CEO: Jess Spinner. Jess is a former professional ballet dancer turned Health Coach and founder of The Whole Dancer. She supports dancers in reaching their body goals through one on one coaching and her online course, The Dancers' Best Body Program. For more on Jess or The Whole Dancer visit thewholedancer.com About Elizabeth Barchi, MD, Staff Physician at Harkness Center for Dance Injuries Dr. Barchi is a board-certified pediatrician with an added qualification in pediatric sports medicine. Her early career with Brandywine Ballet sparked both her passion for dance medicine and her career in the innovation of medical care and training of dancers. During her fellowship training at NYU School of Medicine, she studied dance medicine under the mentorship of Dr. Rose and Dr. Weiss. She is thrilled to be a part of the groundbreaking medical and research teams at Harkness Center for Dance Injuries. About Phillippa Zeignhardt: Philippa danced professionally with the Hamburg Ballet in Germany for 6 years before retraining as a counselor. She founded StageMinded.com in 2011 to equip dancers with the mindset skills they need to survive and succeed in the industry. Philippa is also School Counselor and Performance Psychology teacher at The Australian Ballet School and is mum to 2 crazy little kids. For more information about Philippa, go to Stageminded.com Are you practicing your tip for the day? Share with us on social media and tag @dancetipsdaily to be shared on our platform! Don't forget to follow us on IG and Facebook @dancetipsdaily! Stay up to date with DTD & Subscribe to the once a month newsletter at www.dancetipsdaily.com --- Support this podcast: https://anchor.fm/dance-tips-daily/support
Livehealthy editor Ann Marie McQueen speaks to Dr Javed Raza, a staff physician in the Bariatric Disease Institute at Cleveland Clinic Abu Dhabi. Doctors at the institute have seen an increase in the number of patients seeking medical and surgical treatments for weight loss over the last year. They performed 450 bariatric surgeries in 2020 — with the youngest patient being just 14. Dr Raza talks about the kind of obesity and associated problems that lead people to consider bariatric surgery, what options are available for them when they do, and about how the institute takes a holistic approach with patients to set them up for success.
In this episode of Curbside Consults, we discuss thyroid disorders in pregnancy with Dr. Spyridoula Maraka, Assistant Professor of Medicine at the University of Arkansas for Medical Sciences, Staff Physician at the Central Arkansas Veterans Healthcare System, and...
The Scott Thompson Show Podcast As we wrap up a week that saw the province of Ontario put under a stay-at-home order, Scott welcomed Dr. Isaac Bogoch back to the show to discuss vaccines and variants on a local, provincial and national level. Guest: Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto - There has been more than a little confusion surrounding the vaccination plans for Hamilton's COVID-19 hot spot area codes, including which hot spots the province recognizes and which meet the city's criteria. MPP Donna Skelly joined Scott, to help sort out the seemingly competing pieces of information and tell us exactly which residents in which areas are affected. Guest: Donna Skelly, MPP Flamborough-Glanbrook - A special report from Global News Radio 900 CHML News Director Rick Zamperin, to follow up on the conversation with MPP Skelly. - Dan Moore and his family found a lost piece of 900 CHML history, a recording of his great uncle Clem Burdis appearing on the Paul Hanover Show, sharing his experiences at Vimy Ridge, on the 40th anniversary of the battle. Scott spoke with Dan Moore about his great uncle and the recording. Later in the podcast, we listen to Paul Hanover's full interview with Clem Burdis. Guest: Dan Moore - Patricia Treble joined Scott to reflect on the life of Prince Philip, following this morning's breaking news of his passing. Guest:Patricia Treble, of Write Royalty, Royal contributor to Maclean's - On the 104th anniversary of the start of the battle of Vimy Ridge, Scott replayed Paul Hanover's interview with Clem Burdis, originally broadcast in 1957 on the 40th anniversary of the battle, so we can all hear Clem recount the events of those days. Guests via the restored recording: Clem Burdis, who fought at Vimy Ridge, and owned the Whistle Stop Café in East Hamilton Paul Hanover a.k.a. "the Mayor of the Morning," iconic 900 CHML host Subscribe to the Scott Thompson Show wherever you find your favourite podcasts, keep up with the big stories developing in Hamilton, Ontario and across Canada: https://curiouscast.ca/podcast/189/the-scott-thompson-show/ Host - Scott Thompson Content Producer - Jordan Armenise Technical/Podcast Producer - William P. Erskine See omnystudio.com/listener for privacy information.
Dr. Patel is on faculty at the Penn Medicine Center for Health Care innovation and the Center for Health Incentives and behavioral economics, and a Staff Physician at the Crescenz VA Medical Center in Philadelphia, and a Senior Fellow at the Leonard Davis Institute of Health Economics. His research focuses on combining insights from behavioral economics with scalable technology platforms to improve health and health care. He has led more than 25 clinical trials in partnership with health systems, insurers, employers, and community organizations that tested ways to design nudges, incentives, and gamification to change clinician and patient behavior. This work includes digital health interventions using wearable devices and smartphones, and health system interventions using the electronic health record.
America's Heroes Group Roundtable Veteran's Court with Judge Hooks, Atty Lori Roper, and Atty Brian Scanlon Panelists:Lori Roper- Cook County Supervisor Atty Problem-Solving Courts.Brian Scanlon- Cook County Asst Atty Public Defender Office Dr. Benjamin Bowman - US Army Veteran and Staff Physician at the University of Chicago Pritzker School of Medicine
The Scott Thompson Show Podcast Prime Minister Trudeau announced a tentative agreement with the U.S. company NovaVax that could see Canada producing its own vaccines by the fall. That is good news! However, was such an agreement delayed longer than it could have – or should have – been? Guest: Tim Powers, Vice-Chairman, Summa Strategies, Managing Director of Abacus Data, President of Rugby Canada - The U.S. will see vaccines against the virus that causes COVID-19 shipping to pharmacies in the near future, addressing the problem of distribution. In Canada, our issue is with supply. How do these two situations affect our respective nations’ industries? Guests: Jim Krasula, CBS News Correspondent Marvin Ryder. Business Professor, DeGroote School of Business, McMaster University - We have now seen new variations of SARS-Cov-19 – the coronavirus that causes COVID-19 – arrive appear in Canada. Scott welcomed Dr. Isaac Bogoch to the show, to explain how variant strains of viruses spread, as well as discuss what they mean for Canadians. Guest: Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto - McMaster University’s engineering program and the McMaster chapter of the National Society of Black Engineers announced a new scholarship for black students. President of the NSBE Feyisayo Enuiyin joined Scott to talk about the importance of this scholarship in the engineering community. Guest: Feyisayo Enuin, President of the National Society of Black Engineers - Kamil Karamali joined the show to speak with Scott about the new Global News 5-part series on anti-black racism in 2021. Guest: Kamil Karamali, digital broadcast journalist with Global News See omnystudio.com/listener for privacy information.
Goodathleteproject.com For today's episode we are joined by Dr. Kabran Chapek. Dr. Chapek has worked as a Staff Physician at Amen Clinics since 2013. He is a graduate of Bastyr University in the Seattle area and has a special interest in the assessment and treatment of Alzheimer's and Dementia, traumatic brain injuries, PTSD, and anxiety disorders. He is the Founding President of the Psychiatric Association of Naturopathic Physicians and is the author of “Concussion Rescue: A Comprehensive Program to Heal Traumatic Brain Inury” You can follow Dr. Chapek on Instagram: @DrKabran_Chapek Pick up a copy of his book “Concussion Rescue: A Comprehensive Program to Heal Traumatic Brain Injury” here: https://www.amazon.com/Concussion-Rescue-Comprehensive-Program-Traumatic/dp/0806540230/ref=sr_1_1?crid=UERLGRJBWWAM&dchild=1&keywords=concussion+rescue&qid=1609865493&sprefix=concussion+res%2Caps%2C168&sr=8-1 Follow The Good Athlete Project on Twitter: @Coach4Kindness and Instagram: @GoodAthleteProject. To learn more visit us at our website: GoodAthleteProject.com
When Canadians see a vaccine rollout, what can we expect? What should it look like? Guest: Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto - Prime Minister Justin Trudeau was unable to provide more details on how a coronavirus vaccine will be rolled out across the country early next year during a call with Canada’s premiers Thursday, sources told Global News. According to several people in various premiers’ offices, Trudeau was reluctant to provide details when asked about federal contracts with vaccine makers, including shipments and delivery commitments for initial doses of a vaccine. Guest: Ian Lee, Sprott School of Business, Carleton University - We welcome Cameron Caton back to the show. Who? Sorry, I meant Covid-Elvis! A lot has changed since we last had him on in May to talk about his food drive. Guest: Covid-Elvis, Hamilton musician See omnystudio.com/listener for privacy information.
Another anti-mask/freedom rally is going to be held in London this coming weekend. Dr. Mackie joins the show to discuss the risk these protests bring. Guest: Dr. Christopher Mackie, Medical Officer of Health, Middlesex-London Health Unit. - Canada’s new modelling numbers are projecting that by the end of December we could be seeing 20K cases a day. Guest: Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto. - How are we going to save our failing economy that’s been impacted by COVID-19? According to a piece in The Conversation, we must stomp out the virus. Guest: Blayne Haggart, Associate Professor in the Department of Political Science, Brock University. See omnystudio.com/listener for privacy information.
If we buckled down now, and started implementing heavier rules for the pandemic, could we see the potential for a holiday season? Could we see the government implement stricter rules to allow that to happen? Guest: Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto - A video has emerged of confrontation between OPP and protestors, which was recorded near the Caledonia land reclamation camp. Guest: Ken Hewitt, Mayor of Haldimand - November 5th will be the day when Ontario files it's next budget. With the pandemic, how bad will the hit to our coffers be? Guest: Richard Brennan, retired journalist with the Toronto Star. Covered Queen's Park and Parliament Hill.
Council ruled 12-2 yesterday in favour of reprimanding Cameron Kroetsch after the Integrity Commissioner's report. Does this redefine the role of the Integrity Commissioner? Guest: Peter Graefe. Professor of Political Science, McMaster University Guest: Wade Poziomka. Partner, Ross & McBride. Co-Counsel for HAMSMaRT and Keeping Six, along with Sharon Crowe and Nadine Watson (Hamilton Community Legal Clinic). He represented Cameron Kroetsch in the Integrity Commisioner case. - With projections that by mid October we could be seeing 1000's of cases of COVID-19 a day in Ontario, the government says that going back to Phase two is not imminent. Guest: Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto - Canada's COVID-19 Immunity Task Force (CITF) has announced its support for a new SARS-CoV-2 seroprevalence study focused on aging Canadian, with the Canadian Longitudinal Study on Aging (CLSA), a national platform for research on aging in Canada, and led by McMaster University Guest: Dr. Parminder Raina, the study's Lead Principal Investigator and a Professor in the Department of Health Research Methods, Evidence, and Impact at McMaster University - Should the governments be doing more for business owners? And should the rent subsidies available for businesses go straight to the businesses, not the landlords? Guest: Peggy Sattler, NDP MPP for London-West, Critic, democratic reform, pay equity and employment standards. Also Deputy Opposition House Leader
The Scott Thompson Show Podcast Is the COVID-19 response so far a failure of the system, or is it the failure of a specific party or level of government? Is the system actually broken? Guest: Tim Powers, Vice-Chairman, Summa Strategies, Managing Director of Abacus Data, Chairman of Rugby Canada - COVID-19 testing will be coming to pharmacies across the province, but not all pharmacies will be carrying this practice. Hauser's Pharmacy & Home Healthcare in Hamilton wants to be among those that can provide testing. Guest: Phil Hauser, Hauser's Pharmacy & Home Healthcare - How much will the second wave of COVID-19 affect our holidays? Dr. Isaac Bogoch joined Scott now to discuss second wave worries and Ontario's new rules for combatting the virus. Guest: Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto - Schools are debating getting rid of cold symptoms from the COVID-19 checklist. How would the removal of the cold symptoms from the checklist potentially affect the quality of education? Guest: James Skidmore, Professor, University of Waterloo
In this week's episode, Ryan interviews Dr. Sean Hesler. ND, is the Executive Director of Naturopaths Without Borders. Before graduating from Southwest College of Naturopathic Medicine, Dr. Sean accumulated over 300 clinical hours in global health while elevating NWB from a student organization to the global organization it is today. He co-founded the MamaBaby Haiti birth center in Cap Haitien as Medical Director and Staff Physician for 9 months and now travels between NWB’s sites in Haiti, Mexico, and Phoenix. If you want to reach out to Dr. Sean Hesler, you can find him on Facebook at Naturopaths without Borders or to his email Sean.Hesler@Gmail.com If you have any questions about this podcast or want to get in touch with us, please visit our website www.Holistic-Finance.com where you can make an appointment or learn more about the work we do with Naturopathic Physicians.
The WE Organization is closing its Canadian operations. Opposition argues that by closing only its Canadian operations underscores the ‘lack of due diligence done by government before handing the program to them”. Guest: Andrew Russell, National Online Journalist, Global News. - New revelations are being brought forward in yet another book about the US President by Bob Woodward. In 18 separate interviews, the President spoke with the author about a variety of topics, on record and in audio. One audio clip had the President saying he did not want to scare people with the severity of COVID-19. Guest: Laura Babcock. President, PowerGroup Guest: Reggie Cecchini, Washington Producer and Correspondent with Global News. - One of the vaccines that has been in Phase 3 clinical trials to combat the COVID-19 pandemic has been put on hold after a patient suffered adverse effects. The WHO has said that it's not about racing to get a final product, it's about efficiency. Guest: Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto
Concerns about evictions continue to come up with the eviction ban lifted. In Hamilton, landlords had applied to evict hundreds of tenants over unpaid rent during the State of Emergency from the pandemic. Guest: Tom Cooper, Director, Hamilton Roundtable for Poverty Reduction - Dr. Theresa Tam says that social distancing measures such as masks and the social circles could last longer than the pandemic and could be in place for 2-3 even with a vaccine. Guest: Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto - What are pandemic pods? Some parents are taking education into their own hands due to the COVID-19 pandemic. But what exactly are they, how do they work and what are the benefits? Guest: Rachel Marmer, parent who is doing a pandemic pod for education.
Yesterday, OECTA released a letter expressing their concerns about reopening the schools during the pandemic. Liz Stuart joins Greg to delve into their concerns deeper. Guest: Liz Stuart, President, Ontario English Catholic Teachers Association. - Cases of COVID-19 continue to rise globally. To chat on the latest with COVID-19 and the pandemic, Dr. Isaac Bogoch joins Greg Brady this morning. Guest: Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto - Canadian concert venues are risking permanent shut down due to the COVID-19 pandemic and they're looking for funding to stay afloat. Guest: Alan Cross, music journalist, internationally known broadcaster. - Guest Host: Greg Brady
Today, we're joined by Dr. Anthony Olive (Tony). Tony is a Staff Physician at Texas Children's Hospital, specializing in Gastroenterology, Hepatology, and Nutrition. He's also an associate Professor of Pediatrics at Baylor College of Medicine. We discuss the likelihood and feasibility of developing a vaccine for COVID-19, how kids can safely return to school, what wearing a mask actually does for you, and what's going on inside Houston hospitals. Stay tuned after the interview for a recap and what Dr. Olive's information means for the markets. Comments welcome: Stockbitespodcast@gmail.com Music: Soundcloud.com/thehalftruthsband Enjoy The Show!
A report into last years’ Pride event and altercation will be released today. Guest: John Best. President of the Bay Observer - What change can come from the protests? Already, Minneapolis’ City Council has decided to dismantle the police department there. Guest: Jeffrey G. Reitz, Professor of Sociology; R.F. Harney Professor of Ethnic, Immigration and Pluralism Studies ,Munk School of Global Affairs and Public Policy | University of Toronto - How important is it that we still pay attention to physical distancing rules? 20 somethings in our city are what can be blamed for a spike in COVID-19 cases. ALSO: Canada’s death count rises. Guest: Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto
65 more cases have been announced for the Hamilton area, with a massive outbreak at the Rosslyn Retirement Residence. Mayor Fred joins us to provide an update. Guest: Fred Eisenberger, Mayor, City of Hamilton - One company is saying they're seeing promising results from their vaccine trials and the US President says he's taking hydrochloroquine. To discuss this and how Canada is doing with recovery, Dr. Isaac Bogoch joins the program. Guest: Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto - Joe Biden says that if he becomes president, he will scrap the permits for the Keystone XL pipeline. How will that impact not just the US but us here in Canada? Guest: Marvin Ryder. Business Professor, DeGroote School of Business, McMaster University
Steffan interviews CBS Military Analyst Mike Lyons, Staff Physician at Southwest General Hospital (Cleveland) Mark Meacham, Live Audio from Coronavirus Task Force, and more!See omnystudio.com/listener for privacy information.
The latest from the State Health Department, including new testing centers.Then, we talk to medical professionals about the do's and don'ts on the coronavirus.Plus, how places of worship are adapting to social distancing.Segment 1:This Mississippi Department of Health is introducing a new triage system in an effort to more efficiently test for and identify cases of COVID-19, the disease caused by the novel coronavirus. The University of Mississippi Medical Center is also establishing a testing center at the Fairgrounds in Jackson as a part of this ramped up testing effort. Doctor Alan Jones is the Chair of the Department of Emergency Medicine at UMMC. He explains how the new triage process works.Segment 2:With number of COVID-19 cases in Mississippi expected to grow, health professionals are making efforts to inform communities of the risks associated with coronavirus transmission. Hand hygiene, social distancing, efficient testing measures - are hot topics in the fight against COVID-19. Our Desare Frazier joins Dr. Christian Weaver, Staff Physician in Infectious Diseases at the VA and Southern Remedy's own Dr. Morgan McLeod, Assistant Professor of Internal Medicine and Pediatrics at UMMC to discuss it all.Segment 3:Churches in Mississippi, along with countless others across the country, are suspending Sunday morning worship services in response to the coronavirus. Some, like Broadmoor Baptist Church in Madison, are utilizing already-existing technologies, like live-streams to continue reaching its 4,000 member congregation. Pepper Carter is the Communications and Events Minister at Broadmoor. She tells MPB's Ashley Norwood that although the church has been streaming services for years, the overall Sunday experience is still different for most. Jerry Young is pastor over the 3,000 member congregation at New Hope Baptist Church in Jackson. He admits there are some challenges transitioning Sunday morning worship services online. But, he tells our Ashley Norwoood, it would be irresponsible for the church to ignore experts and their guidelines. See acast.com/privacy for privacy and opt-out information.
Sports play an important role in our culture, from the individual level where many participate in recreational activities for exercise and social benefits, to the national and international levels where professional sports are a huge industry worth billions. Sports can strongly unite people, but athletes of every level from the weekend warrior to the professional athlete can face challenges that remind us that there is a team behind the team – helping maintain their mental and physical health! In this episode we hear from inspiring speakers sharing their insights from the worlds of medicine, research and professional athlete development. Dr. Doug Richards kicks things off, he is the Medical Director and Staff Physician practicing sport and exercise medicine at the David L. MacIntosh Sport Medicine Clinic, Chief Medical Officer at the Canadian Sport Institute of Ontario, and Assistant Professor in the Faculty of Kinesiology and Physical Education at the University of Toronto. Next up to the plate is Dr. Gretchen Kerr, the Vice Dean of Programs at the School of Graduate Students and Professor in the Faculty of Kinesiology and Physical Education at the University of Toronto specializing in athlete maltreatment. Karl Subban earns the hat trick with his inspirational personal experiences as an educator and in raising five elite children, including the development of 3 NHL Players. In the spirit of teamwork, this episode was created in collaboration with Medicine in Motion. Until next time, #keepitraw Medicine In Motion Podcast Athlete Maltreatment Among National Athletes Study and Summary Athlete Mental Health
Sports play an important role in our culture, from the individual level where many participate in recreational activities for exercise and social benefits, to the national and international levels where professional sports are a huge industry worth billions. Sports can strongly unite people, but athletes of every level from the weekend warrior to the professional athlete can face challenges that remind us that there is a team behind the team – helping maintain their mental and physical health! In this episode we hear from inspiring speakers sharing their insights from the worlds of medicine, research and professional athlete development. Dr. Doug Richards kicks things off, he is the Medical Director and Staff Physician practicing sport and exercise medicine at the David L. MacIntosh Sport Medicine Clinic, Chief Medical Officer at the Canadian Sport Institute of Ontario, and Assistant Professor in the Faculty of Kinesiology and Physical Education at the University of Toronto. Next up to the plate is Dr. Gretchen Kerr, the Vice Dean of Programs at the School of Graduate Students and Professor in the Faculty of Kinesiology and Physical Education at the University of Toronto specializing in athlete maltreatment. Karl Subban earns the hat trick with his inspirational personal experiences as an educator and in raising five elite children, including the development of 3 NHL Players. In the spirit of teamwork, this episode was created in collaboration with Medicine in Motion. Until next time, #keepitraw Medicine In Motion Podcast Athlete Maltreatment Among National Athletes Study and Summary Athlete Mental Health
The Scott Thompson Show Podcast With two more COVID-19 cases being confirmed in Toronto bringing Ontario's total to 34, Scott spoke with Dr. Isaac Bogoch about how the disease is progressing in Canada. Guest: Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor, Dept. of Medicine, University of Toronto - Professor Wendy E. Parmet joined the show to add an American perspective the conversation, and discuss how the U.S. is handling the COVID-19 situation. Guest: Wendy E. Parmet, Matthews University Distinguished Professor of Law and Professor of Public Policy and Urban Affairs, Northeastern University - Ian Lee of the Sprott School of Business spoke with Scott about COVID-19's effect on the world economy, and China's future. Guest: Ian Lee, of the Sprott School of Business at Carleton University - PR Expert Elissa Freeman joined Scott to discuss how governments and organizations are handling the messaging around COVID-19. Guest: Elissa Freeman. Public Relations Consultant, Huffington Post, Canada.com and PR Daily
There's been a fall in cases of Covid19, caused by the new coronavirus known as SARS-CoV-2. Wait, what? Dr. Isaac Bogoch joins Scott to explain the name changes, as well as what the newest numbers say about the disease. Guest: Dr. Isaac Bogoch, Staff Physician, General Internal Medicine and Infectious Diseases Associate Professor with the Dept. of Medicine at the University of Toronto Like what you hear? Check out the Scott Thompson Show Podcast, available wherever you find your favourite shows! https://omny.fm/shows/scott-thompson-show/the-complicated-issues-of-the-pipeline-protests-un
Dr. Conners has been studying alternative cancer care for over 18 years. He is the Staff Physician and Clinic Director at the Conners Clinic, an alternative cancer treatment center in St Paul, MN. Dr. Conners is also certified in Functional Neurology and has had over 300 hours of postgraduate study in the Autism Spectrum Disorders. and is trained and certified in Epigenetic Clinical Methylation and Nutrigenomics. He has written numerous books including "Stop Fighting Cancer and Start Treating the Cause". Today Dr. Conners talks about his practice and what differentiates him from other cancer clinics. He explains what a Rife machine is and which type is best for healing cancer, as well as how to determine which diet will work best for you. As a gift to our listeners, Dr. Conners has given FREE accessto all of his ebooks.
Dr. Uri Tabori is a Staff Physician in the Division of Haematology/Oncology, Senior Scientist in the Genetics & Genome Biology program, and Principal Investigator of The Arthur and Sonia Labatt Brain Tumour Research Centre at The Hospital for Sick Children (SickKids). In addition, Uri is a Professor in Paediatrics and Associate Professor in the Institute of Medical Sciences at the University of Toronto. Uri works as a physician treating kids with cancer, particularly brain tumors. Through his research, he is working to identify drugs and make new discoveries that may cure cancers or improve patients’ lives. When he’s not hard at work in the lab or clinic, Uri enjoys spending time with his family, watching American football, and exploring the wilderness of Canada. In particular, he is fond of canoeing and canoe camping with his family. He received his MD from the Hadassah School of Medicine of Hebrew University in Israel. Afterwards, he completed a Rotating Internship and his Residency in Pediatrics at the Sorasky Medical Center in Israel. Next, Uri accepted a Fellowship in Pediatric Hematology and Oncology at the Sheba Medical Center in Israel. He served as a Staff Physician in Pediatric Hematology and Oncology at The Sheba Medical Center for about a year before accepting a Research and Clinical Fellowship at The Hospital for Sick Children in Canada SickKids where he remains today. Over the course of his career, Uri has received numerous awards and honors, including the Early Researcher Award from the Ontario Ministry of Development and Innovation, the New Investigator Award from the Canadian Institute of Health Research, the Junior Physician Research Award from the University of Toronto Department of Pediatrics, The New Investigator Award from the Terry Fox Foundation, A Eureka! new investigator award from the International Course of Translational Medicine, A Merit Award from the American Society of Clinical Oncology Annual Meeting, and The Young Investigator Award from the Canadian Neuro-Oncology Society. In our interview, Uri shares more about his life, science, and clinical care.
Dr. Kevin Conners, D.PSc., FICT, FAARFM is the Staff Physician and Clinic Director at Conners Clinic, an Alternative Cancer Treatment center in St Paul, MN. He graduated with his doctorate from Northwestern Health Sciences University in 1986 and has been studying alternative cancer care for over 18 years. He also holds AMA Fellowships and Board […] The post Dr Kevin Conners Discusses Cancer/Rife Treatment at the Conners Clinic appeared first on Holistic Health Show.
Today’s episode covers the emotionally charged topic of cancer. Cancer affects 1 in 2.25 people in the United States today, and is quickly on track to advance to 1 in 2. The tendency of most people, once handed a diagnosis of cancer, is to react (understandably) from a place of shock and fear. Dr. Kevin Conners suggests taking the time to do research and consider the alternative treatments available, if possible, before resorting to the “big guns”—radiation, chemotherapy, and surgery. Dr. Kevin Conners is the Staff Physician and Clinic Director at Conners Clinic, an Alternative Cancer Treatment Center in St Paul, MN. He’s been studying alternative cancer care for over 18 years. He has written numerous books including “Stop Fighting Cancer and Start Treating the Cause” that is available as a free download at ConnersClinic.com/books. It would be difficult to find someone who has not been affected in some way by cancer. In troubling times like these, isn’t it great to have access to so much information? Genetic testing can go far to inform us how our unique bodies respond to different natural supplements and protocols when it comes to treating cancer. We have the ability to listen to our bodies and the power to choose our path of treatment. Why not make the most informed decisions possible? Resources mentioned in this week’s episode include: Frankincense essential oil Lemongrass and cinnamon essential oils connersclinic.com connersclinic.com/books Submit a Recipe to the DIY Dugout by emailing diy@revolutionoilspodcast.com OR by using the Hashtags #diydugout and #revolutionoilspodcast on Instagram. Thank you to our amazing sponsors this week: This episode is sponsored by Modern Fertility. Visit modernfertility.com/revolution →Take their fertility quiz and get $20 off your Modern Fertility test. This episode is sponsored by Daily Harvest →Get $25 off your first box when you use promo code REVOLUTION View our entire sponsor list at www.revolutionoilspodcast.com/sponsors
The Essential Oil Revolution –– Aromatherapy, DIY, and Healthy Living w/ Samantha Lee Wright
Today’s episode covers the emotionally charged topic of cancer. Cancer affects 1 in 2.25 people in the United States today, and is quickly on track to advance to 1 in 2. The tendency of most people, once handed a diagnosis of cancer, is to react (understandably) from a place of shock and fear. Dr. Kevin Conners suggests taking the time to do research and consider the alternative treatments available, if possible, before resorting to the “big guns”—radiation, chemotherapy, and surgery. Dr. Kevin Conners is the Staff Physician and Clinic Director at Conners Clinic, an Alternative Cancer Treatment Center in St Paul, MN. He’s been studying alternative cancer care for over 18 years. He has written numerous books including “Stop Fighting Cancer and Start Treating the Cause” that is available as a free download at ConnersClinic.com/books. It would be difficult to find someone who has not been affected in some way by cancer. In troubling times like these, isn’t it great to have access to so much information? Genetic testing can go far to inform us how our unique bodies respond to different natural supplements and protocols when it comes to treating cancer. We have the ability to listen to our bodies and the power to choose our path of treatment. Why not make the most informed decisions possible? Resources mentioned in this week’s episode include: Frankincense essential oil Lemongrass and cinnamon essential oils connersclinic.com connersclinic.com/books Submit a Recipe to the DIY Dugout by emailing diy@revolutionoilspodcast.com OR by using the Hashtags #diydugout and #revolutionoilspodcast on Instagram. Thank you to our amazing sponsors this week: This episode is sponsored by Modern Fertility. Visit modernfertility.com/revolution →Take their fertility quiz and get $20 off your Modern Fertility test. This episode is sponsored by Daily Harvest →Get $25 off your first box when you use promo code REVOLUTION View our entire sponsor list at www.revolutionoilspodcast.com/sponsors
Tim and Jeff are joined by Dr. Roger Chou on this week's episode of Pain Reframed! A professor and physician at Oregon Health & Science University (OHSU), Dr. Chou was part of the team that developed the CDC's Guideline for Prescribing Opioids for Chronic Pain in 2016. More recently, he co-published an editorial in the New England Journal of Medicine, examining the current state of opioid prescribing in the United States. Tim, Jeff, and Dr. Chou discuss the impact of both of these works and the steps we can take in our clinics to make sure we're always putting the patient first. Dr. Roger Chou is a Professor in the Departments of Medicine, and Medical Informatics & Clinical Epidemiology at Oregon Health & Science University (OHSU) School of Medicine, and Staff Physician in the Internal Medicine Clinic at OHSU. He has served as Director of the Pacific Northwest Evidence-based Practice Center since 2012. He has conducted systematic reviews in a number of areas, including chronic pain and musculoskeletal conditions, screening and prevention, diagnostic testing, and prognosis. He has served as Director of the American Pain Society clinical guidelines program, the GRADE methodologist for the World Health Organization’s Division of Reproductive Health, is a member of the Cochrane Back Review Editorial Board, and co-chair of the National Quality Forum Musculoskeletal Standing Committee. Dr. Chou is on several journal editorial boards and is an author on numerous scientific articles published in peer-reviewed journals. LINKS: Twitter - @ISPITeam No Shortcuts to Safer Opioid Prescribing (New England Journal of Medicine) Learn more about the roles that physical therapists and physical therapy assistants can play in reducing the opioid epidemic
Members from Team Telomere (formerly DC Outreach), a community for telomere biology disorders join me for this episode. This panel includes patient advocate Katie Stevens, Dr. Sharen Savage, and Dr. Suneet Agarwal. They provide information and support services to families worldwide who are affected by these disorders, encourage the medical community’s research in finding causes and effective treatments, and facilitate improved diagnosis by educating medical providers.Katie Stevens is the Executive Director of Team Telomere. Her oldest child, Riley, is affected by a telomere disorder. Katie’s goal is to be an advocate and resource. She is also a member of Global Genes Foundation Alliance Advisory Council and a NORD member leader.Dr. Sharon Savage is the Chief of the Clinical Genetics Branch in the Division of Cancer Epidemiology and Genetics at the National Cancer Institute (NCI). She leads clinical, genetic, and epidemiologic studies of individuals and families at high risk of cancer. Dr. Savage’s research program in telomere molecular epidemiology incorporates population-based studies of telomere length and disease with genetic studies of telomere biology. She serves as a Medical Advisor for Team Telomere.Dr. Suneet Agarwal completed his M.D. and Ph.D. training at Harvard Medical School. He is currently an Assistant Professor in Pediatrics at Harvard Medical School, Principal Faculty at the Harvard Stem Cell Institute and Harvard Initiative in RNA Medicine, and Staff Physician in Hematopoietic Cell Transplantation at the Dana-Farber / Boston Children’s Cancer and Blood Disorders Center. Dr. Agarwal's research and clinical work is focused on the mechanisms and treatment of genetic blood disorders. He leads a multi-center bone marrow transplant clinical trial for dyskeratosis congenita, and his lab is working on new therapeutic approaches for telomere diseases. He also serves as a Medical Advisor for Team Telomere.This Episode We DiscussKatie’s Son’s Diagnostic JourneyDyskeratosis Congenita and Telomere Biology DisorderPrevalenceSymptomsAge of OnsetAssociated GenesDiagnosis ProcessTreatmentsLatest ResearchHow Team Telomere Helps Affected FamiliesBecoming a Bone Marrow Donor > BeTheMatch.orgStay tuned for the next new episode of DNA Today on November 2nd, 2018. New episodes are released on the first and third Fridays of the month. Can’t wait? There are over 90 episodes to explore in the meantime.See what else I am up to on Twitter, Instagram, Facebook and iTunes. Questions/inquiries can be sent to Kira at info@DNApodcast.com.
Fumihiko Urano, MD, Samuel E. Schechter Professor of Medicine, Staff Physician at Barnes-Jewish Hospital Washington University School of Medicine
You've tried to quit smoking and finding it more difficult than you ever imagined.You've decided it's time to quit but don't know where to begin.Should I try e-cigarettes?Will I gain weight?Is there any medication that could help?Dr. Brian Tiep, Staff Physician, Division of Pulmonary and Critical Care Medicine at City of Hope, is here to answer these and other important questions to aid you in your attempt to quit smoking.
Learn About the Anti-Inflammatory, Anti-Neoplastic Effect of Curcumin as It Relates to Colon Cancer Prevention Kirk Hamilton interviews Dr. Robert E.Carroll, M.D., Associate Professor of Medicine and Staff Physician at the University of Illinois Medical Center, and, a Staff Physician at the Jesse Brown VA Medical Center. His major research focus concerns the expression and function of gastrin-releasing peptide (GRP) and its receptor. This research focus shows that these proteins are almost always aberrantly expressed by cancers of the GI tract. His clinical research focuses on way to discover the earliest premalignant changes in esophageal (Barretts mucosa), gastric (intestinal metaplasia), and colonic epithelium (aberrant crypt foci). Dr. Carroll co-authored a paper entitled "Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia," in Cancer Prevention Research in March of 2011. Download or Open:
Martin and Scott discuss the work of Robert H. Keller MD, MS, FACP Named as one of the world's 2,000 Outstanding Scientists of the 21st Century, and has served on the scientific review panels for the National Institutes of Health and the VA. The Consumer' Research Council has named Dr. Keller one of America's Top Physicians in 2003, 2004, 2005, 2006, and 2007 in the fields of Internal Medicine, Immunology and Hematology. Max International. In 1994, Dr. Robert H. Keller founded The BIODORON Institute of Advanced Medicine, a state-of-the-art medical clinic specializing in cutting-edge treatment for immune system disorders and anti-aging. Dr. R.H. Keller, MD MS FACP, Medical & Research Director of The Biodoron institute of advanced medicine and the CEO and director of research of Vit-Immune, Inc. had a distinguished academic career after medical school at Temple University and training in Internal Medicine, Immunology and Hematology at the University of Rochester and the Mayo Clinic. During a fellowship and subsequent Assistant Professorship at the Mayo Graduate School of Medicine, he introduced a new laboratory technology to identify cells at the Mayo Clinic. Moving to Milwaukee, he became a faculty member in the Departments of Medicine, Pediatrics, Biophysics and Health Science at the Medical College of Wisconsin (Marquette University) and the University of Wisconsin, where he rose to level of Professor. He was also awarded two career development awards (Clinical Investigatorships) and the Superior Performance Award (for research) by the Veteran's Administration where he served as a Staff Physician and Director of the Marcus Center for Immunology Research. During his academic tenure, he was awarded over 2 million dollars in research grants from both the NIH and VA; served on the scientific review panels for the NIH and VA; published over 100 original articles, invited reviews and book chapters in Immunology, Hematology and Medicine; was awarded two patents and served many consultantships including NASA during the Apollo Program. In 1994, Dr. Robert H. Keller founded The BIODORON Institute of Advanced Medicine, a state-of-the-art medical clinic specializing in cutting edge treatment for immune system disorders and anti-aging. Each week Martin Pytela and Scott Paton discuss Holistic principles for healthy living. Life Enthusiast Co-op is built on over 25 years in study, health consultations and market research in the field of holistic and alternative medicine. We deliver solid time tested expertise. We are in this business not for the money, but for the passion, we have for sharing with others what we had to learn the hard way, through experience. We focus on high quality, innovative holistic solutions. Length: 25:00 Go to iTunes and review our podcast: iTunes Life Enthusiast Reviews and 5 star ratings If You Enjoyed This, Please Go To "FANS OF THIS SHOW" On The RIGHT And Then Click On "BECOME A FAN". In Addition, PLEASE CLICK On The “SEND TO A FRIEND” At The Bottom Of This Podcast…. COPY THE DATA And SEND THIS, and “My Pod Home Page URL”, To EVERYONE In Your ADDRESS BOOK…. FRIENDS Or ENEMIES! WANT TO BE NOTIFIED OF NEW EPISODES? ~~~~~~~~~~~~~~~~~~~~ Go To “Join my mailing list ” On The RIGHT………. When It Comes Up You Will See On This Page “Add me to Life Enthusiast''s mailing list:” ………. And Then type in your name and email address ………. Now Just Click “Save”. Technorati Tags: weight loss, Diet, Obesity, Dieting, Healthy Living,Food, Exercise, Fitness, Nutrition, Supplements, Lose Weight, Martin Pytela, Scott Paton.
On September 18, 2008 at the Koshland Science Museum in Washington, D.C., Dr. Stuart Levy, professor of Molecular Biology and Microbiology at Tufts University School of Medicine and Dr. Linda Tollefson, Assistant Commissioner for Science at the U.S. Food and Drug Administration, discussed how to optimize antibiotic use and how to minimize the emergence of drug resistant pathogens. In part 2 of this 3 part video series, Dr. Levy discusses how antibiotic resistance develops, the development practices drug companies employ when producing antimicrobials, and how this process may change in the future. Dr. Tollefson outlines how the FDA is encouraging the development of antibiotics in an industry that is mostly focussed on manufacturing drugs for chronic illnesses. Dr. Levy is Professor of Molecular Biology and Microbiology at Tufts University School of Medicine where he is the Director of the Center for Adaptation Genetics and Drug Resistance. He directs research on mechanisms of bacterial antibiotic resistance. Stuart Levy is also Staff Physician at the Tufts Medical Center and he also serves as the president of The International Alliance for the Prudent Use of Antibiotics. Dr. Tollefson is Assistant Commissioner for Science at the U.S. Food and Drug Administration (FDA). She previously served as Deputy Director of the Center for Veterinary Medicine (CVM), where she led CVM's efforts to implement a risk-based approach to address antimicrobial resistance, fulfilling a 2001 Congressional mandate, and was instrumental in the founding of the National Antimicrobial Resistance Monitoring System for Enteric Bacteria. Tollefson also served as Chief of Epidemiology in the Center for Food Safety and Applied Nutrition where she successfully investigated numerous outbreaks of food borne disease and served as liaison to the Centers for Disease Control and Prevention.
On September 18, 2008 at the Koshland Science Museum in Washington, D.C., Dr. Stuart Levy, professor of Molecular Biology and Microbiology at Tufts University School of Medicine and Dr. Linda Tollefson, Assistant Commissioner for Science at the U.S. Food and Drug Administration, discussed how to optimize antibiotic use and how to minimize the emergence of drug resistant pathogens. In part 2 of this 3 part video series, Dr. Levy discusses how antibiotic resistance develops, the development practices drug companies employ when producing antimicrobials, and how this process may change in the future. Dr. Tollefson outlines how the FDA is encouraging the development of antibiotics in an industry that is mostly focussed on manufacturing drugs for chronic illnesses. Dr. Levy is Professor of Molecular Biology and Microbiology at Tufts University School of Medicine where he is the Director of the Center for Adaptation Genetics and Drug Resistance. He directs research on mechanisms of bacterial antibiotic resistance. Stuart Levy is also Staff Physician at the Tufts Medical Center and he also serves as the president of The International Alliance for the Prudent Use of Antibiotics. Dr. Tollefson is Assistant Commissioner for Science at the U.S. Food and Drug Administration (FDA). She previously served as Deputy Director of the Center for Veterinary Medicine (CVM), where she led CVM's efforts to implement a risk-based approach to address antimicrobial resistance, fulfilling a 2001 Congressional mandate, and was instrumental in the founding of the National Antimicrobial Resistance Monitoring System for Enteric Bacteria. Tollefson also served as Chief of Epidemiology in the Center for Food Safety and Applied Nutrition where she successfully investigated numerous outbreaks of food borne disease and served as liaison to the Centers for Disease Control and Prevention.
On September 18, 2008 at the Koshland Science Museum in Washington, D.C., Dr. Stuart Levy, professor of Molecular Biology and Microbiology at Tufts University School of Medicine and Dr. Linda Tollefson, Assistant Commissioner for Science at the U.S. Food and Drug Administration, discussed how to optimize antibiotic use and how to minimize the emergence of drug resistant pathogens. In part 2 of this 3 part video series, Dr. Levy discusses how antibiotic resistance develops, the development practices drug companies employ when producing antimicrobials, and how this process may change in the future. Dr. Tollefson outlines how the FDA is encouraging the development of antibiotics in an industry that is mostly focused on manufacturing drugs for chronic illnesses. Dr. Levy is Professor of Molecular Biology and Microbiology at Tufts University School of Medicine where he is the Director of the Center for Adaptation Genetics and Drug Resistance. He directs research on mechanisms of bacterial antibiotic resistance. Stuart Levy is also Staff Physician at the Tufts Medical Center and he also serves as the president of The International Alliance for the Prudent Use of Antibiotics. Dr. Tollefson is Assistant Commissioner for Science at the U.S. Food and Drug Administration (FDA). She previously served as Deputy Director of the Center for Veterinary Medicine (CVM), where she led CVM's efforts to implement a risk-based approach to address antimicrobial resistance, fulfilling a 2001 Congressional mandate, and was instrumental in the founding of the National Antimicrobial Resistance Monitoring System for Enteric Bacteria. Tollefson also served as Chief of Epidemiology in the Center for Food Safety and Applied Nutrition where she successfully investigated numerous outbreaks of food borne disease and served as liaison to the Centers for Disease Control and Prevention. Part 3 will be published next week.
Will we become defenseless against bacteria? Will bacteria always find a way to infect and even kill us? The emergence of antibiotic resistant strains of bacteria poses an enormous problem around the world. Scientists believe that the overuse of antibiotics is increasing the appearance of these pathogens. In the US, increasing casualties resulting from drug resistant staphylococcus infections received wide media attention. While antibiotics only work on bacterial infections, many patients and doctors regard antibiotics as a front-line form of treating any type of infection. Antibiotics are often prescribed because the specific pathogen that is causing an illness is often difficult to determine. In some cases they are used as a preventative measure. But is this the best defense? Are there ways to beat bacteria at their own game? On September 18, 2008 at the Koshland Science Museum in Washington, D.C., Dr. Stuart Levy, professor of Molecular Biology and Microbiology at Tufts University School of Medicine and Dr. Linda Tollefson, Assistant Commissioner for Science at the U.S. Food and Drug Administration, discussed how to optimize antibiotic use and how to minimize the emergence of drug resistant pathogens. In part 1 of this 3 part video series, Dr. Levy discusses the basics of microbial pathogens, bacteria, and antibiotic resistance. And, Dr. Tollefson outlines the various types and classes of antibiotic drugs, approved uses, and current levels of effectiveness. Dr. Levy is Professor of Molecular Biology and Microbiology at Tufts University School of Medicine where he is the Director of the Center for Adaptation Genetics and Drug Resistance. He directs research on mechanisms of bacterial antibiotic resistance. Stuart Levy is also Staff Physician at the Tufts Medical Center and he also serves as the president of The International Alliance for the Prudent Use of Antibiotics. Dr. Tollefson is Assistant Commissioner for Science at the U.S. Food and Drug Administration (FDA). She previously served as Deputy Director of the Center for Veterinary Medicine (CVM), where she led CVM's efforts to implement a risk-based approach to address antimicrobial resistance, fulfilling a 2001 Congressional mandate, and was instrumental in the founding of the National Antimicrobial Resistance Monitoring System for Enteric Bacteria. Tollefson also served as Chief of Epidemiology in the Center for Food Safety and Applied Nutrition where she successfully investigated numerous outbreaks of food borne disease and served as liaison to the Centers for Disease Control and Prevention.
Will we become defenseless against bacteria? Will bacteria always find a way to infect and even kill us? The emergence of antibiotic resistant strains of bacteria poses an enormous problem around the world. Scientists believe that the overuse of antibiotics is increasing the appearance of these pathogens. In the US, increasing casualties resulting from drug resistant staphylococcus infections received wide media attention. While antibiotics only work on bacterial infections, many patients and doctors regard antibiotics as a front-line form of treating any type of infection. Antibiotics are often prescribed because the specific pathogen that is causing an illness is often difficult to determine. In some cases they are used as a preventative measure. But is this the best defense? Are there ways to beat bacteria at their own game? On September 18, 2008 at the Koshland Science Museum in Washington, D.C., Dr. Stuart Levy, professor of Molecular Biology and Microbiology at Tufts University School of Medicine and Dr. Linda Tollefson, Assistant Commissioner for Science at the U.S. Food and Drug Administration, discussed how to optimize antibiotic use and how to minimize the emergence of drug resistant pathogens. In part 1 of this 3 part video series, Dr. Levy discusses the basics of microbial pathogens, bacteria, and antibiotic resistance. And, Dr. Tollefson outlines the various types and classes of antibiotic drugs, approved uses, and current levels of effectiveness. Dr. Levy is Professor of Molecular Biology and Microbiology at Tufts University School of Medicine where he is the Director of the Center for Adaptation Genetics and Drug Resistance. He directs research on mechanisms of bacterial antibiotic resistance. Stuart Levy is also Staff Physician at the Tufts Medical Center and he also serves as the president of The International Alliance for the Prudent Use of Antibiotics. Dr. Tollefson is Assistant Commissioner for Science at the U.S. Food and Drug Administration (FDA). She previously served as Deputy Director of the Center for Veterinary Medicine (CVM), where she led CVM's efforts to implement a risk-based approach to address antimicrobial resistance, fulfilling a 2001 Congressional mandate, and was instrumental in the founding of the National Antimicrobial Resistance Monitoring System for Enteric Bacteria. Tollefson also served as Chief of Epidemiology in the Center for Food Safety and Applied Nutrition where she successfully investigated numerous outbreaks of food borne disease and served as liaison to the Centers for Disease Control and Prevention.
Guest: Barbara Gabriel, MA Host: Michael Greenberg, MD Dr. Michael Greenberg speaks with Barbara Gabriel, Associate Editor of Physicians Practice Journal about how to ensure physicians you hire for your practice will stay with you.